The QualityStocks Daily Wednesday, December 21st, 2022

Today's Top 3 Investment Newsletters

MarketClub Analysis(SINT) $11.7400 +57.16%

QualityStocks(CENN) $0.4041 +51.86%

MarketBeat(MGAM) $0.9156 +43.02%

The QualityStocks Daily Stock List

SINTX Technologies (SINT)

StockMarketWatch, QualityStocks, TradersPro, BUYINS.NET, StocksEarning, InvestorPlace, Trades Of The Day, The Stock Dork, The Online Investor, StreetInsider, MarketClub Analysis, MarketBeat and InvestorIntel reported earlier on SINTX Technologies (SINT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SINTX Technologies Inc. (NASDAQ: SINT) (FRA: 111N) is an original equipment manufacturing ceramics firm that is engaged in researching, developing, manufacturing and commercializing silicon nitride for non-medical and medical applications in South America, Europe and the U.S.

The firm has its headquarters in Salt Lake City, Utah and was founded 1996 by Ashok C. Khandkar and Aaron A. Hofmann. Prior to its name change in October 2018, the firm was known as Amedica Corporation. It operates in the materials industry, under the chemicals sub-industry and serves consumers from different parts of the globe.

The company is party to a collaboration agreement with Oxford Performance Materials Inc. which entails the development of a silicon nitride composite that will be based off of the solution casting technology by OXPEKK SC. It generates product revenue mainly from the sale and manufacture of spinal fusion products utilized in treating spine disorders.

The enterprise provides ceramic-based solutions for various anti-pathogenic, industrial and medical applications. Its pipeline comprises of silicon nitride coating, silicon nitrite powder, porous and solid silicon nitride products. Silicon nitride is compatible and bioactive across all imaging modalities, which provides patients and surgeons with a preferable alternative to the commonly used materials. Additionally, the enterprise is involved in the development of corrosion-and wear-resistant implant components for knee and hip joint replacements and markets spinal fusion products.

After entering into an agreement with 02TODAY in February 2021, the firm recently sold its first shipment of anti-pathogenic silicon nitride powder which is used in the manufacture of mask filters and face masks. With the pandemic raging on, this collaboration is bound to bring in more revenue as well as attract investors into Sintx.

SINTX Technologies (SINT), closed Wednesday's trading session at $11.74, up 57.162%, on 20,984,552 volume with 00 trades. The average volume for the last 3 months is 117,415 and the stock's 52-week low/high is $6.46 /$83.57 .

SmartMetric Inc. (SMME)

Wall Street Resources, SmallCapFinancialWire, QualityStocks, PennyStocks24, The Green Baron, Stock Traders Chat, SmallCapVoice, Wall Street Stallions, Wall St Insider Stocks, TopPennyStockMovers, PoliticsAndMyPortfolio, OTCPicks, Greenbackers and Bull in Advantage reported earlier on SmartMetric Inc. (SMME), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SmartMetric, Inc. (OTCQB: SMME) is a technology engineering, research and development stage firm that develops miniature electronic systems and software to be used in the field of biometric identification and validation for the corporate and government sectors as well as the payments industry.

The firm has its headquarters in Las Vegas, Nevada and was incorporated in 2002, on December 18th by Chaya Coleena Hendrick. The firm operates as part of the other miscellaneous manufacturing industry and serves consumers around the globe.

The company operates in the technology industry and is involved in the development of its biometric technology. It is the sole licensee of biometric smart card technology. Smart cards possess an integrated circuit chip and an embedded onboard fingerprint sensor. The company has research and development centers in Tel-Aviv, Palo Alto and Argentina.

The enterprise’s products include a security card with a functional fingerprint reader and finger sensor embedded inside the card, with a rechargeable battery for portable card activation and biometric identification. This card is known as the SmartMetric Biometric Card. It also develops the SmartMetric biometric payment cards which offer security for debit and credit cards by adding biometric authentication and activation to the Visa, MasterCard and EuroPay chip cards, which are used around the globe.

Biometric cards are a game changer for the banking industry, with the firm’s biometric card solution advancing credit card security and eliminating the use of PINs at the ATM. The firm is set to make millions in additional revenue as biometric cards are adopted on a large scale, which will not only extend their consumer reach but also boost their growth significantly.

SmartMetric Inc. (SMME), closed Wednesday's trading session at $0.002, up 53.8462%, on 93,931,250 volume with 00 trades. The average volume for the last 3 months is 162,688 and the stock's 52-week low/high is $0.0009 /$0.046 .

Cenntro Electric Group (CENN)

TradersPro, QualityStocks and InvestorPlace reported earlier on Cenntro Electric Group (CENN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cenntro Electric Group Ltd (NASDAQ: CENN) (FRA: 0SQ) is a commercial electric car technology firm that is focused on manufacturing electric medium-duty and light commercial vehicles.

The firm has its headquarters in Freehold, New Jersey and was incorporated in 2017, on May 11th. Prior to its name change, the firm was known as Naked Brand Group Ltd. It operates as part of the auto manufacturers industry, under the consumer cyclical sector. The firm serves consumers across the globe, with a primary focus on those in the United States and Australia.

The company’s business model enables it to design, manufacture, assemble and sell electric vehicles to third parties for distribution and services to end-users. Its objective is to lead transformation in the automotive industry via decentralized and scalable production and the development of fully digitalized autonomous driving solutions.

The enterprise’s electric vehicles have been designed to serve various governmental and corporate organizations in support of last-mile delivery services, city services and other commercial applications. These electric vehicle models include the ORV, Neibor 200, Logistar 400 and the Metro. It also distributes already manufactured car kits which are usually assembled, homologated, serviced and sold by 3rd parties in different markets. The enterprise has also developed an in-house telematics box which enables its electric vehicles to receive and send data concerning acceleration, speed, location, battery consumption and braking.

The firm recently entered into an agreement to acquire majority interest in Tropos Motors Europe. This move will speed up the firm’s expansion into Europe, Africa and the Middle East, increase its revenues and bring it closer to becoming a major provider of electric commercial mobility.

Cenntro Electric Group (CENN), closed Wednesday's trading session at $0.4041, up 51.8602%, on 47,081,749 volume with 00 trades. The average volume for the last 3 months is 77,891 and the stock's 52-week low/high is $0.26 /$7.80 .

Galmed Pharmaceuticals (GLMD)

MarketBeat, StockMarketWatch, BUYINS.NET, QualityStocks, Kiplinger Today, StreetInsider,, InvestorPlace, MarketClub Analysis, TraderPower, Flagler Financial Group, Planet Penny Stocks, Daily Trade Alert, Penny Pick Finders, OTCtipReporter, Buzz Stocks, Penny Stock 101, PennyStockScholar, Profitable Trader Authority, Schaeffer's, Stock Gumshoe, Stock News Now, StockOnion, StockOodles, StreetAuthority Daily, TopStockAnalysts and PennyStockProphet reported earlier on Galmed Pharmaceuticals (GLMD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) is a biopharmaceutical firm which is engaged in the development and commercialization of oral therapy treatments of inflammatory, metabolic and liver diseases such as cholesterol gallstones and non-alcoholic steatohepatitis (NASH).

Galmed Pharmaceuticals was founded in 2000 by Tuvia Gilat and Allen Baharaff. Mr. Baharaff has served as the firm’s CEO since 2012 and its President from 2015. The firm is part of the Scientific Research and Development Services Industry in the country and has its headquarters in Tel Aviv-Jaffa, in Israel.

The company provides its products to medical and healthcare industries. Galmed Pharmaceuticals Ltd developed a synthetic bile-acid/fatty-acid conjugate, known as Aramchol. The compound, which is an ailment modifying treatment for fatty liver disorders, is the drug candidate for treating fibrosis and NASH in an ongoing Phase 3 ARMOR study. The compound has demonstrated that it can improve metabolic parameters linked to NASH while also decreasing liver fat content.

As of early 2021, Galmed Pharmaceuticals Ltd had published their findings from their phase 3 ARMOR study on the efficacy of Aramchol, after their discovery confirmed that Aramchol could potentially be used to treat non-alcoholic steatohepatitis patients who have fibrosis.

There are currently no medicines approved to treat non-alcoholic steatohepatitis. Galmed Pharmaceuticals Ltd. being the first to find an effective treatment would open up doors to more research into their candidates, which would earn the firm a lot of opportunities as well as investments.

Galmed Pharmaceuticals (GLMD), closed Wednesday's trading session at $0.4511, up 45.5161%, on 1,510,147 volume with 00 trades. The average volume for the last 3 months is 189,320 and the stock's 52-week low/high is $0.29 /$2.1799 .

Lixiang Education (LXEH)

StreetInsider reported earlier on Lixiang Education (LXEH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lixiang Education Holding Co. Ltd (NASDAQ: LXEH) is an investment holding firm engaged in the provision of education services.

The firm has its headquarters in Lishui, China and was incorporated in August 2001 by Fen Ye. Prior to its name change in May 2020, the firm was known as Lianwai Education Group Ltd. It operates as part of the education and training services industry, under the consumer defensive sector. The firm mainly serves consumers in the People’s Republic of China.

The enterprise primarily offers private primary and secondary education services and is responsible for student admission and progression. It is designated as the Foreign Language Experimental School of the National Basic Foreign Language Teaching Research Center. Here, it offers bilingual teaching and implements small-class teaching and boarding management. It is also the base of arts, sports, Chinese calligraphy and small-class education. It not only offers the standard People's Republic of China (PRC) curriculum programs, but also places an emphasis on featured curriculum programs. It also offers high school education services at its High School Division through its collaborations. In addition to this, it is involved in the operation of food procurement and information technology development businesses.

The company remains focused on expansion, which will not only help extend its consumer reach but also allow it to better meet its consumer needs. This is in addition to generating additional revenues for the company, which will in turn create significant value for its shareholders.

Lixiang Education (LXEH), closed Wednesday's trading session at $2.56, up 15.8319%, on 100 volume with 00 trades. The average volume for the last 3 months is 9.985M and the stock's 52-week low/high is $1.82 /$10.20 .

Navitas Semiconductor Corp. (NVTS)

MarketBeat, Schaeffer's and InvestorPlace reported earlier on Navitas Semiconductor Corp. (NVTS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Navitas Semiconductor Corp. (NASDAQ: NVTS) is a power-semiconductor firm that is focused on designing, developing and marketing gallium nitride (GaN) power integrated circuits used in charging and power conversion.

The firm has its headquarters in El Segundo, California and was incorporated in 2013. It operates as part of the semiconductors industry, under the technology sector. The firm serves consumers around the globe.

The company’s primary objective is to electrify the world using next-generation power electronics and to enable and accelerate the transition to fast, efficient, and clean forms of sustainable energy. It operates in Germany, the United States, Ireland, China, Italy, Belgium, the Philippines and Taiwan.

The enterprise develops a range of ultra-efficient gallium nitride (GaN) semiconductors such as analog and mixed-signal, wide-band gap materials, machine learning, quantum computing, and wireless devices. Its GaN power ICs are developed for high frequency, soft-switching applications and have been designed to integrate GaN power with drive, control and protection to enable charging, power density, and energy savings. Power supplies incorporating its products are used in a range of electronics products including mobile phones, consumer electronics, data centers, solar inverters and electric vehicles. The enterprise serves the mobile, consumer, enterprise, eMobility and new energy markets.

The firm’s next-gen GaNFast power ICs were used by Xiaomi Redmi for their recently released ultra-fast smartphone chargers. It is open to more collaborations that’ll push GaN technology innovation while extending its reach globally. This will in turn bolster the firm’s overall growth while also creating shareholder value.

Navitas Semiconductor Corp. (NVTS), closed Wednesday's trading session at $3.65, up 6.1047%, on 790,852 volume with 00 trades. The average volume for the last 3 months is 6,818 and the stock's 52-week low/high is $3.389 /$17.338 .

Discovery Silver (DSVSF)

We reported earlier on Discovery Silver (DSVSF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Discovery Silver Corp. (OTCQX: DSVSF) (CVE: DSV) (LON: 0A61) (FRA: 1CU0) is a mineral exploration firm that is focused on exploring for and developing polymetallic deposits.

The firm has its headquarters in Toronto, Canada and was incorporated in 1986, on October 10th. Prior to its name change, the firm was known as Discovery Metals Corp. It operates as part of the silver industry, under the basic materials sector. The firm serves consumers around the globe.

The enterprise primarily explores for silver, lead and zinc deposits. Its flagship property is the Cordero silver project, which is located on the eastern edge of the Sierra Madre Occidental mountains in the northern part of the Central Mexican Silver Belt, Mexico’s premier porphyry and carbonate replacement deposit district. The project covers an area of approximately 35,000 hectares located in the Chihuahua state, Mexico. It also holds an option agreement to purchase 100% interest in the Puerto Rico, La Kika, Minerva, Monclova, and Santa Rosa pipeline projects in Mexico. The Puerto Rico project is a multi-target carbonate replacement silver-zinc-lead mining district; while the Monclova project is found roughly 25km southwest of the city of Monclova. The Minerva project is located roughly 30km west of the La Encantada silver mine owned by First Majestic Silver Corp.

The company recently provided an update on its ESG initiatives, with its CEO noting that they were focused on transforming Cordero into one of the biggest silver mines around the globe. This move will not only increase the project’s production but also bring in additional revenues and investments into the company.

Discovery Silver (DSVSF), closed Wednesday's trading session at $0.9382, up -0.021313%, on 198,690 volume with 00 trades. The average volume for the last 3 months is 909,374 and the stock's 52-week low/high is $0.63405 /$1.755 .

Pervasip Corp (PVSP)

PennyStocks24, Stock Legends,, Bull in Advantage, Nebula Stocks, AwesomePennyPicks, QualityStocks, GoldmanStockReport, SmallCapVoice, Stockpalooza, OTC Advisors, OTCPicks, SmallMovesBigGains, Light Speed Stocks, Manny Smith, PennyTrader Publisher, Investor News Source, Wise Alerts, FeedBlitz, BreakthroughStocks Team, PennyInvest, BullRally, CashMoneyPlays, PennyStockVille, SteroidStocks, CoolPennyStocks, ShamrockStocks, Fast Money Plays, BestFreePennyAlerts, Beacon Equity Research, HotOTC, HotStockChat, AwesomePennyStocks, GoldminePennyStocks, SimplyBestPennyStocks, TradeThesePicks, Top Best Pennystocks,, StockRich, Stock Traders Chat, OTCReporter, Stock Analyzer, MadPennyStocks, ShamrockCap,, PennyTrader, Penny Stock Rumble, Mega Stock Picks, MarketBeat and Stock Preacher reported earlier on Pervasip Corp (PVSP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Pervasip Corp. (OTC: PVSP) is a company engaged in the development and delivery of products and technologies to agricultural markets.

The firm has its headquarters in White Plains, New York and was incorporated in 1964, on July 22nd. Prior to its name change in December 2007, the firm was known as eLEC Communications Corp. It operates as part of the advertising agencies industry, under the communication services sector. The firm mainly serves consumers in the US.

The company is primarily focused on developing and investing in firms and technologies in high value emerging markets, specifically Cannabis and Medical Fungi. It owns and operates a retail hydroponic store in Denver, Colorado. The company operates through its subsidiaries, which include Plaid Canary Corp (PCC) and Canalytix LLC (Canalytix). Grow Big Supply LLC (Grow Big Supply) is a subsidiary of PCC.

The enterprise develops cloud-based applications to monitor and control greenhouse facilities. It intends to develop scientific methods for the analysis of cannabinoids in flowers, concentrates, and edibles; and assist medical marijuana specialty production facilities to regulate, calculate proper dosage, and understand the importance of consistency in product. This will help improve grow conditions, yields and value in hydroponic and other indoor grow facility applications.

The firm, which recently acquired Dabco brand and Emerald City Cultivation, is committed to capturing additional market share while pursuing its strategic goals. This will open it up to new growth and investment opportunities, which will positively influence its growth and create shareholder value.

Pervasip Corp (PVSP), closed Wednesday's trading session at $0.001, up 0%, on 13,178,758 volume with 00 trades. The average volume for the last 3 months is 276,377 and the stock's 52-week low/high is $0.0006 /$0.0038 .

Arqit Quantum (ARQQ)

MarketClub Analysis,, StocksEarning, Schaeffer's, QualityStocks and MarketBeat reported earlier on Arqit Quantum (ARQQ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Arqit Quantum Inc. (NASDAQ: ARQQ) is engaged in the provision of cybersecurity services through satellite and terrestrial platforms.

The firm has its headquarters in London, the United Kingdom and was incorporated in 2021, on April 26th by David James Bestwick and David John Williams. It operates as part of the software-infrastructure industry, under the technology sector. The firm serves consumers in the United Kingdom.

The company mission is to use its transformational quantum encryption technology to keep safe the data of governments, enterprises and citizens. It operates in one segment; the provision of cybersecurity services via satellite and terrestrial platforms. The company generates the majority of its revenues from the UK.

The enterprise supplies quantum encryption platform-as-a-service, which makes the communications links of networked devices secure against cyber attacks. Its products include QuantumCloud, a Platform as a Service that creates unbreakable software encryption keys. These unbreakable software encryption keys are easy to use and have universal application to every edge device and cloud machine, as well as unique quantum encryption technology which makes the communications links of any networked device secure against cyber attack. This platform also solves the problems of legacy encryption techniques. The enterprise also offers maintenance and support, and other related professional services.

The firm, which recently released its latest financial results, remains focused on accelerating its go-to-market strategy and driving its growth. This will, in turn, open the firm up to new investment opportunities and generate significant shareholder value.

Arqit Quantum (ARQQ), closed Wednesday's trading session at $4.38, up 3.7915%, on 232,101 volume with 00 trades. The average volume for the last 3 months is 3.442M and the stock's 52-week low/high is $3.80 /$26.90 .

Riot Blockchain Inc. (RIOT)

Schaeffer's, MarketClub Analysis, StocksEarning, InvestorPlace, StockMarketWatch, MarketBeat, QualityStocks, TradersPro, The Street, Market Intelligence Center Alert, Zacks, Kiplinger Today, The Online Investor, BUYINS.NET, TraderPower, Trades Of The Day, Daily Trade Alert, Trading Tips, Market Intelligence Center, Penny Stock 101, PennyStockLocks, AllPennyStocks, StockRockandRoll, StreetAuthority Daily, Promotion Stock Secrets, StockEarnings, TopPennyStockMovers, Louis Navellier, InvestorsUnderground, Investors Alley, StreetInsider, The Daily Market Alert and Money Morning reported earlier on Riot Blockchain Inc. (RIOT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Following the new anti-monopoly law of the European Union, Apple intends to allow apps from third-party app stores to operate on its devices, which could mean significant gains for developers of NFT and cryptocurrency apps in the Europe region.

A Bloomberg report released on Dec. 13, 2022, stated that European customers can install substitute apps outside of Apple’s exclusive app store under the new regulations, eventually enabling users to install apps that are not subject to Apple’s 30% fee and that are free of restrictions.

At the moment, Apple has imposed strict restrictions on NFT applications, effectively requiring users to pay a 30% commission fee for IOS purchases while existing apps aren’t allowed to accept crypto payments.

Recently, Coinbase’s wallet app update was blocked by the tech giant in a squabble over the company’s stringent requirements to collect a 30% fee via the in-app purchase. According to Coinbase, the tech company wanted the platform to disable NFT transactions if they could not be completed via the in-app purchase requirement.

Coinbase claimed that the move was not possible, and users who would be affected by the decision — iPhone users — would have a more difficult time transferring that NFT to other wallets. Coinbase further stated that the block might have been a mistake and urged Apple to get in touch with the platform if there were any problems.

Apple’s decision to make its systems more accessible is a response to the European Union’s Digital Markets Act (DMA), which seeks to regulate door guards and ensure platforms act responsibly and fairly by enhancing collaboration between the gatekeepers and third parties.

However, Apple has not made it clear whether it intends to abide by a provision of the act that allows developers to embed other payment systems within non-app store applications. To comply with the provision, Apple would have to allow payment methods that support NFTs and cryptocurrencies.

To protect its users from potentially harmful applications, the tech company plans to add security requirements, such as verification, for software that is not downloaded from the app store.

The transition is expected to begin in May 2023, although companies have until 2024 to fully comply with the DMA. Only the EU would benefit from the changes to Apple’s restrictive environment; other territories will be required to formulate legislation with a similar effect, such as the Open App Markets Act proposed by Senators Richard Blumenthal and Marsha Blackburn for the U.S. Congress.

As more jurisdictions tweak their rules around blockchain either through legislative processes or through the court system, a suitable environment for industry actors such as Riot Blockchain Inc. (NASDAQ: RIOT) will gradually emerge.

Riot Blockchain Inc. (RIOT), closed Wednesday's trading session at $3.83, up 0%, on 6,217,839 volume with 00 trades. The average volume for the last 3 months is 170,648 and the stock's 52-week low/high is $3.60 /$26.79 .

Hecla Mining Company (HL)

MarketClub Analysis, SmarTrend Newsletters, Schaeffer's, InvestorPlace, Wyatt Investment Research, MarketBeat,, StocksEarning, Top Pros' Top Picks, QualityStocks, TopStockAnalysts, StreetAuthority Daily, Market Report, The Street, Money Morning, Zacks,, Jason Bond, Kiplinger Today, Daily Trade Alert, StreetInsider, Today's Financial News, Wall Street Grand, Trades Of The Day, TheStockAdvisors, Streetwise Reports, StockOodles, The Wealth Report, TradersPro, Gryphon Digest, Penny Detectives, National Inflation Association, SureMoney, TradingAuthority Daily, Stockhouse, Darwin Investing Network, ChartAdvisor, PennyStockLive, Options Elite, INO Market Report, Wall Street Daily, Penny Sleuth, Profit Confidential, ProfitableTrading, TraderPower, The Growth Stock Wire, Daily Markets, Greenbackers, Forbes, DrStockPick, Wealth Insider Alert, TradingMarkets, WealthMakers, Investopedia, CustomerService, CRWEWallStreet, CRWEPicks, CRWEFinance, Weiss Research, BestOtc, Barchart, Daily Wealth,, AllPennyStocks, PennyToBuck, MonsterStocksPicks, Residual Income Report, Money and Markets, Rockwell Trading, Investing Futures, Stock Stars, Traders For Cash Flow, StockHotTips, Trade of the Week, InvestorGuide, Investor Update, Investor Guide, Investing Lab, PennyOmega and SmallCapVoice reported earlier on Hecla Mining Company (HL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The world’s transitioning from the use of fossil fuels in favor of clean energy will advance the development of energy-storage technologies while also limiting greenhouse-gas emissions globally. The primary goal of the transition is to mitigate climate change, as stipulated in the 2015 Paris Agreement. Achieving this will require considerable investments from both public and private entities, the use of technological innovations and various regulatory interventions.

Renewable energy-generation technologies and electric cars are some of the technologies required in this transition. These technologies require substantial amounts of critical minerals, which mean the demand for critical minerals is expected to increase as the global energy infrastructure changes.

The International Energy Agency’s Sustainable Development Scenario forecasts that the low-carbon energy sector’s demand for these minerals will grow exponentially by 2040. In a scenario where the Paris Agreement’s objectives are met, the agency expects that the demand for cobalt and lithium from energy transition technologies will be 21 and 42 times higher than the levels recorded in 2020.

However, the increasing reliance on critical minerals may cause an imbalance in the demand and supply for those minerals, which in turn, could create conditions for resource nationalism to grow. Resource nationalism refers to the tendency of governments and individuals to exert control over natural resources found in their territories.

Maplecroft’s 2021 Political Risk Outlook established a growing risk of resource nationalism in more than 30 countries. Increasing resource nationalism will create conflicts between the interests of producers wanting to maximize production in response to the demand brought on by the energy transition and the interest of states wanting to maximize the value of their natural resources.

This, among other things, has given rise to other hurdles that will make it hard to achieve the needed production of critical minerals without compromising the objective of the energy transition. Other challenges include a lack of investment in exploration, which has reduced the number of projects that potential investors can readily inject their funds into.

It doesn’t help that the forward trajectory for capital expenditure in the mining industry is far from encouraging. According to a Wood Mackenzie analysis, the total capital expenditure is expected to drop by more than 70% by 2026. Additionally, a lack of collaborations between producers and governments will make it hard for the mining industry to meet future demand for critical minerals.

This is why it is necessary for governments and miners to collaborate in the creation of fiscal terms that will ensure fair distribution of the economic benefits of resources while also allowing a high rate of return to encourage more investment.

These industry challenges could well be opportunities for entities such as Hecla Mining Company (NYSE: HL) that focus on extracting these critical minerals needed during the energy transition.

Hecla Mining Company (HL), closed Wednesday's trading session at $5.6, up 0.5386%, on 7,327,904 volume with 00 trades. The average volume for the last 3 months is 368,451 and the stock's 52-week low/high is $3.41 /$7.66 .

Lordstown Motors Corp. (RIDE)

Green Car Stocks, Schaeffer's, InvestorPlace, QualityStocks, StocksEarning, The Street, MarketBeat, MarketClub Analysis, Trades Of The Day, Early Bird, Daily Trade Alert, The Online Investor, CNBC Breaking News, Kiplinger Today, StreetInsider, BUYINS.NET, The Stock Dork and Cabot Wealth reported earlier on Lordstown Motors Corp. (RIDE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Consumer Reports’ survey gathers information from thousands of vehicle owners, including major breakdowns they may have encountered while operating their vehicles. This historical data is then applied to project the credibility and dependability of EVS. Even though the findings of this survey indicate that electric vehicles generally experience lots of problems compared to other kinds of vehicles, the results this year had some promising developments from Tesla and Nissan as they take the lead.

In terms of how reliable the vehicles are, the Nissan LEAF comes in third, with the Tesla Model 3 coming second. First place goes to the brand-new Kia EV6 crossover, but as Consumer Reports points out, there is not enough information or time to evaluate its reliability properly. Overall, these three cars are recommended by Consumer Reports. However, despite being more reliable than other EVs, many internal combustion engines still outperform them.

Consumer Reports’ results point out that a lot of the most recent electric vehicles are manufactured by companies that have been known for making internal combustion engines for more than a century, and these companies are currently learning in regard to making electric vehicles. However, Tesla and Nissan tend to have a distinct advantage over many rivals because they have been in the business of mass-producing electric vehicles for more than a decade now. As a result, models such as the Nissan Leaf and the Tesla Model 3 have fewer known EV problems, such as those related to charging, batteries and motors, while other companies are still struggling to adjust to the EV transition.

The Model 3 stands out from the rest of the Tesla series of vehicles, thanks to its generally high reliability. However, other vehicles from Tesla continue to be subpar. The more recent Model Y, which in some ways resembles the Tesla Model 3, still exhibits issues with suspension, body hardware and hatch closing, as well as paint and trim. The costly Model S and Model X have also been seen to be having issues with air suspension as well.

Reliance on electric vehicles will continue to increase as long as automakers are continually designing and refining their electric vehicles and as long as the technology continues to spread. However, currently the two models, namely the Nissan Leaf and the Tesla Model 3, remain dependable options. Additionally, the Model 3 also benefits from Tesla’s top-notch charging system and makes a strong case for early adoption.

Newer startups such as Lordstown Motors Corp. (NASDAQ: RIDE) have their work cut out for them to catch up to the early leaders in this nascent industry.

Lordstown Motors Corp. (RIDE), closed Wednesday's trading session at $1.16, up -2.521%, on 3,685,536 volume with 00 trades. The average volume for the last 3 months is 79,221 and the stock's 52-week low/high is $1.12 /$4.235 .

The QualityStocks Company Corner

Vision Energy Corp. (OTCQB: VENG)

The QualityStocks Daily Newsletter would like to spotlight Vision Energy Corp. (OTCQB: VENG).

The WEF projects that if all current low-carbon hydrogen projectsbeing planned are brought online, by 2030, low-carbon capacitycould reach 16-24 Mt. annually, with green hydrogen accounting for9-14 Mt. and blue hydrogen accounting for between 7 and 10 Mt.

VENG recognizes the challenges present in the green hydrogen spaceand, through its hydrogen production-via-electrolysis, is lookingto offer a more viable and approachable energy solution thataddresses the issues at hand

The company has plans underway to secure multiple locations inEurope for the planning, development, construction, and futureoperations of clean hydrogen production facilities

The glaring low supply of green hydrogen, coupled with the highcurrent and anticipated future demand for the product, presents avast opportunity for VENG, even as it looks to scale up itsoperations and position itself as a leader in the renewable energyspace

In 2021, demand for hydrogen reached 94 million tons, up from apre-pandemic total of 91 MT in 2019, according to the InternationalEnergy Agency (“IEA”). This demand represented about 2.5% of globalfinal energy consumption, yet, the production of low-emissionshydrogen only accounted for less than 1 Mt. The World EconomicForum (“WEF”) projects that if all current low-carbon hydrogenprojects being planned are brought online by 2030, low-carboncapacity could reach 16-24 Mt. annually, with green hydrogenaccounting for 9-14 Mt and blue hydrogen accounting for between 7and 10 Mt. (


Vision Energy (OTCQB: VENG) today provided a project development update on the company’s GreenEnergy Hub in the North Sea Port of Vlissingen, the Netherlands.According to the update, Vision Energy, through its wholly ownedsubsidiary Evolution Terminals BV, is concluding remainingrequisite studies to support filing permit applications under theDutch “WABO” process, with targeted first submission by Dec. 31,2022. The submission includes filing of an environmental permitfollowed by construction permit application for phase 1 400,000cubic meters (“CBM”) capacity. The latter will be a phasedsubmission, with each phase designed in accordance with commercialstorage requirements for the future planned expansion capacity forgreen and low-carbon energy products at the terminal. The companyis on schedule to file the detailed environmental impact assessmentknown in the Netherlands as the “MER” (“Milieueffectrapport”)before Jan. 31, 2023, in compliance with the formal process and inclose cooperation with the authorities.

To view the full press release, visit

Vision Energy Corp. (OTCQB: VENG) (“Vision Energy”) is a forward-looking energy company developing carbon reduced solutions for the commercial, industrial and transportation sectors. Vision Energy is leveraging its team’s proven track-record in site and asset procurement, accelerating development and permitting processes, plant design, and grid integration to facilitate low-carbon energy production, supply and distribution. The company is pursuing reliable offtake relationships and operating partnerships with energy industry participants and end users seeking carbon abatements across feedstock and fuels. Vision Energy is committed to providing low carbon energy solutions with maximized yield, with projects designed to exploit existing gas and power infrastructure, to integrate and facilitate import and/or distribution of reduced-carbon energy to domestic and global supply chains.

The company believes that hydrogen and liquid carriers of hydrogen are the most reliable alternatives to fossil fuels. Hydrogen is anticipated by many energy analysts to become more widely competitive as an alternative mobile energy source as early as 2030, as economies of scale drive down costs.

According to the International Energy Agency report ‘Hydrogen in North-Western Europe (2021)’, the region is well placed to lead hydrogen adoption as a clean energy source. Today, this region comprises approximately 5% of global hydrogen demand and 60% of European demand. Moreover, the region is home to the largest industrial ports in Europe, where much of this hydrogen demand is located, and presents a well-developed natural gas infrastructure connecting these ports with other industrial hubs. This gas network could be partially repurposed to facilitate hydrogen delivery from production sites to demand centers. Governments in this region also have ambitious goals for greenhouse gas emissions reduction and there is strong political interest in hydrogen as a pathway to maintaining industrial activity in the region.

Vision Energy is based in Jersey City, New Jersey.


Through wholly owned subsidiary Evolution Terminals BV, Vision Energy is pioneering a Green Energy Hub development project for the import, storage and distribution of low-carbon renewable fuels and hydrogen carriers, strategically located in the North Sea port of Vlissingen at the mouth of the Westerschelde estuary in the Netherlands. This Green Energy Hub is positioned to be the first terminal in Europe focused on green and low-carbon energy products.

Vision Energy is at an advanced stage of planning for the construction of its Green Energy Hub and is on schedule to file for the remaining construction and environmental permits by December 2022. The Green Energy Hub design is capable of receiving seagoing vessels, barges and coasters, served by a dedicated deep-water jetty as well as rail and truck loading infrastructure that will enable direct access to purpose-built storage and handling facilities for low-carbon fuels and hydrogen carriers, including ammonia, methanol and liquid organics. Phase 1 capital expense is estimated at approximately €450 million, including jetty infrastructure, and will provide for up to 400,000 cubic meters (CBM) of storage capacity with land already secured for future expansion.

Market Opportunity

In Northwestern Europe, the market for green hydrogen, or hydrogen produced by renewable energy, is growing rapidly. The current hydrogen demand projections outstrip the scheduled production for the next five to 10 years.

The company believes that all producers will face high demand. Moving beyond its initial Green Energy Hub, Vision Energy is focused on countries where governments support a regulatory standard that promotes hydrogen production and consumption. Many governments have established various incentives and financial mechanisms to accelerate and promote the use of hydrogen as a renewable energy source.

The EU, through its European Green Deal, has set an objective to become climate-neutral by 2050, implying the near total phase-out of fossil fuels in the EU energy system, and many countries are working to put in place subsidy programs for the development of green hydrogen facilities in anticipation of this goal.

Vision Energy projects its total addressable market at €10 billion by 2050.

Management Team

Andrew Hromyk is CEO of Vision Energy. He has supported and operated chemical and energy operations in the Permian Basin, central and south Texas, Arkansas, Alberta and internationally. An active investor, he has been involved with companies developing a diverse range of technologies, from enhanced and conventional hydrocarbon recovery processes to wireless infrastructure. He has participated in numerous industrial and commercial real estate developments. He also has served as a director of several private companies that became publicly traded on Nasdaq, NYSE and TSX. He studied economics at Chaminade University and the University of British Columbia.

Arron Smyth is Executive Vice President of Corporate Development at Vision Energy. He has more than 18 years of experience in financial services, investment banking, business leadership and operations in both developed and emerging markets. Since 2018, he has been Managing Director Europe for the First Finance group of companies, developing and supporting the group’s private equity investments and projects, including Evolution Terminals, the Netherlands-based developer of tank terminal and port infrastructure for the bulk storage and handling of clean and sustainable energy products.

Matthew Hidalgo is CFO of Vision Energy. He has over 15 years of experience in accounting, operations, finance, corporate restructuring and integrating acquisitions. He is a Managing Partner at Turquino Equity LLC, a private equity investment firm. Formerly, he was the controller and operations manager for the largest subsidiary of WPCS International Incorporated. Prior roles included managing accounting functions for several Australian subsidiaries. After graduating from Penn State with a bachelor’s degree in accounting, he began his career at PricewaterhouseCoopers.

Vision Energy Corp. (OTCQB: VENG), closed Monday's trading session at $2.05, up 3.0151%, on 73,251 volume with 375 trades. The average volume for the last 3 months is 57,207 and the stock's 52-week low/high is $1.04999995/$5.63000011.

Recent News

HeartBeam Inc. (NASDAQ: BEAT)

The QualityStocks Daily Newsletter would like to spotlight HeartBeam Inc. (NASDAQ: BEAT) .

BEAT has developed technology that collects data to synthesize a12-lead 3D vector electrocardiogram (“VECG”)

The device provides physicians with a 12-lead ECG associated withchest pain compared to a baseline ECG for the patient

This key data enables physicians to assess whether symptoms may bethe result of a heart attack

HeartBeam’s (NASDAQ: BEAT) small, portable, easy-to-use heart-attack detection solution wasthe focus of a recent Big Biz Show episode; the Big Biz Showfeatures fast-talking, hard-hitting discussions on business andfinance. During the interview, Big Biz Show host Bob “Sully”Sullivan chatted with HeartBeam founder and CEO Branislav Vajdic,PhD, about the company’s groundbreaking new device, the HeartBeamAIMIGo(TM) 12-lead 3D vector electrocardiogram recording devicethat is designed to detect heart attacks anytime, anywhere (

HeartBeam Inc. (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector 12-lead electrocardiogram (ECG) platform for heart attack detection anytime, anywhere. The company’s proprietary ECG telehealth technology aims to redefine the way high risk cardiovascular patients are diagnosed in ambulatory and acute care settings. HeartBeam’s initial focus is on providing diagnostic data to help physicians with care management of patients with cardiovascular disease.

In August 2022, HeartBeam announced that it submitted its HeartBeam AIMI™ software for approval from the U.S. Food and Drug Administration (FDA). HeartBeam AIMI is a platform technology to improve the speed and accuracy of heart attack detection in acute care settings. The company expects FDA approval by the end of 2022, and a full commercial roll-out of HeartBeam AIMI is targeted for Q1 2023.

HeartBeam sees submission of its first product based on its platform technology as an important milestone toward commercialization, which underscores the company’s continued progress toward making the HeartBeam AIMI platform widely available to help emergency department physicians quickly and accurately identify a heart attack.

While the FDA conducts its regulatory review, HeartBeam will focus on executing key components of its commercialization plan and subscription revenue model. It will also continue to engage in discussions with strategic institutions, including academic centers, regional healthcare systems and regional community hospital systems that can utilize HeartBeam products.

The company is based in Santa Clara, California.


HeartBeam’s development portfolio includes two products:

  • HeartBeam AIMI is software that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately identify a heart attack in acute care settings and, as noted above, has been submitted for FDA approval; and
  • HeartBeam AIMIGo™, the first and only credit card-sized 12-lead output ECG device coupled with a smartphone app and cloud-based diagnostic software system for remote heart attack detection.

HeartBeam is developing AIMIGo, a medical-grade detection and monitoring technology for use in remote heart attack detection, thereby allowing physicians to diagnose a patient’s heart attack as it occurs, even if the patient is not at a medical facility. The company’s system, once approved by the FDA, can be used by patients at home or almost anywhere and anytime to help their physicians assess whether chest pain is the result of a heart attack or another cause. While approximately 82% of chest pain ED visits are unnecessary, patients delay approximately 3 to 4 hours after symptoms begin, increasing mortality rates by 40%. The company’s goal is to shorten the time to treatment outside of the medical facility to improve patients’ well-being.

HeartBeam’s AIMIGo is a powerful, portable and easy-to-use prescription-based product. It comprises a smartphone app, a credit card-sized ECG device placed on a patient’s chest, the HeartBeam cloud platform, and a digital portal for the physician to view ECG results and direct patient action. For the first time outside of a medical setting, HeartBeam AIMIGo enables patients and their clinicians to determine if symptoms are due to a heart attack, quickly and easily, so care can be expedited, if needed.

Pending FDA clearance, AIMIGo is initially intended to be available by prescription, and is reimbursable under existing remote patient monitoring codes (RPM codes). This provides a new revenue stream to physicians who before did not have a way to monitor these high-risk patients. The RPM codes provide a monthly reoccurring revenue stream to the company, as well. On average, at current reimbursement rates, the practice will receive $1,300+ per year per patient they monitor, and the company will receive $600 per year per patient from this RPM reimbursement.

Market Overview

Adoption rates of telehealth services increased dramatically in recent years, with the COVID-19 pandemic serving as a major driver of growth. Among the areas seeing the greatest expansion are cardiology, radiology, behavioral health and online consultation.

Encouraging this growth, governments are actively developing new policies and reimbursement guidelines to promote the use of digital health platforms. The U.S. Centers for Medicare & Medicaid Services (CMS), for example, has recently expanded reimbursement for telehealth services. U.S. market growth is also being driven by the rising prevalence of chronic conditions and the growing geriatric population.

Remote heart attack detection is a previously unsolved problem with a massive and underserved market that is several times larger than the $2 billion total addressable market (TAM) in the U.S. for ECG cardiac arrhythmia monitoring.

Approximately 8 million Americans have suffered at least one heart attack, and a total of 18 million have been diagnosed with coronary artery disease (CAD). Based on these figures, HeartBeam projects a total addressable U.S. market TAM valued at $10 billion annually for its AIMIGo solution for remote heart attack monitoring of CAD.

Management Team

Branislav Vajdic, Ph.D., Chief Executive Officer and Founder of HeartBeam, Inc, combines over 30 years of experience in technology development and senior management positions. Dr. Vajdic has been deeply involved with the development of HeartBeam’s technology to fit his vision for the company. Prior to HeartBeam, from 2007 to 2010, Dr. Vajdic was CEO and Founder of NewCardio, a publicly traded company in the cardiovascular devices space. From 1984 to 2007, Dr. Vajdic was at Intel, where he held various senior management position. At Intel, Dr. Vajdic was the designer of first Flash memory and two key inventions that enabled Flash as a product and led engineering groups responsible for Pentium 1 through Pentium 4 designs. Dr. Vajdic was awarded two Intel Achievement Awards, the highest level of award for outstanding contributions to Intel. Dr. Vajdic is author of numerous patents and publications in the fields of cardiovascular devices, as well as chip design. Dr. Vajdic holds a Ph.D. in Electrical Engineering from the University of Minnesota.

Jon Hunt, Ph.D., has over 35 years’ experience in the medical/medical device industry with extensive domestic and international experience in general management, clinical/regulatory, sales and marketing. He also has diverse experience in Fortune 500 companies, as well as start-up environments. Dr. Hunt was the Vice President of Clinical Science and Technology, Medical Device Innovation Consortium, from July 2019 to July 2021, and Vice President of Clinical and Regulatory Affairs, Cryterion Medical from January 2018 to June 2019 (acquired by Boston Scientific Corporation in July 2018 for $202M). Dr. Hunt was the Founding President and CEO of Bardy Diagnostics, Inc. from October 2013 to November 2017 (acquired by Hill-Rom Holdings, Inc.). Prior to joining Bardy Diagnostics, Dr. Hunt spent the previous 11 years as the Vice President of Clinical & Regulatory Affairs with Cameron Health, Inc. (acquired by Boston Scientific Corporation). Dr. Hunt spent the previous 10 years with Cardiac Pacemakers, Inc., St. Jude Medical and Cardiac Pathways Corporation. Dr. Hunt began his career with Cardiac Pacemakers, Inc. (now Boston Scientific Corporation) as the Director of Clinical Programs. He subsequently held positions at St. Jude Medical in Clinical Affairs and as the Business Unit Director for the Cardiac Rhythm Management division for Europe, the Middle East and Africa. At Cardiac Pathways Corporation, Dr. Hunt held various executive positions as Vice President of International Sales and Marketing and Vice President of Worldwide Sales and Marketing (acquired by Boston Scientific Corporation). Dr. Hunt received his Ph.D. in Motor Control from The Pennsylvania State University, his Master’s from California State University, Long Beach and his undergraduate degree from Keele University in the United Kingdom.

Rick Brounstein, HeartBeam’s Chief Financial Officer, combines over 30 years of experience in health technology senior management. Since 2017, Mr. Brounstein has been and is currently a partner of Hardesty, LLC, a financial services firm, and Mr. Brounstein is currently a managing director of CTRLCFO, LLC, a firm Mr. Brounstein founded in 2016 to support funded start-ups in life science and technology. From 2008 to 2011, Mr. Brounstein was Chief Financial Officer of NewCardio, Inc., a microcap public company in the cardiology space, and, over his career, he has been with nine other companies in life science or technology, holding positions including Chief Financial Officer, Chief Operating Officer, Treasurer and Accounting Manager. From June 2001 through November 2007, Mr. Brounstein held several positions at Calypte Biomedical Corporation, a publicly traded medical device company, including Chief Financial Officer and Executive Vice President. In January 2007, Mr. Brounstein was appointed as the National Member Representative for the 2007 COSO Monitoring Project, which published new guidelines for monitoring internal financial controls in February 2009; Mr. Brounstein subsequently was a member of the FEI task force that issued the updated COSO Internal Control Framework in 2013. In March 2005, Mr. Brounstein was appointed to the SEC Advisory Committee on Smaller Public Companies. Mr. Brounstein earned his Certified Public Accountant (CPA) certification while working at Arthur Andersen LLP, formerly a public accounting firm. Mr. Brounstein holds a B.A. in accounting and an M.B.A. in finance, both from Michigan State University.

Ken Persen, HeartBeam’s Chief Technology Officer, combines over 28 years of experience in the medical device and digital health industries in engineering and senior management positions. Mr. Persen has been involved in several companies in Cardiac Rhythm Management, holding positions including Chief Executive Officer, Chief Technology Officer, Executive Vice President and Director of Engineering. Since 2016 and prior to joining HeartBeam, Mr. Persen was the Chief Technology Officer at LIVMOR, Inc., a digital health company. In addition, from 2016 through November 2021, he was also Chief Executive Officer of LIVMOR. Prior roles included Director of Engineering at Cameron Health (acquired by Boston Scientific), a late-stage medical device start up, and engineering and management positions at Guidant Corp. (acquired by Boston Scientific), a large medical device manufacturer. He has an undergraduate degree from University of Minnesota, Duluth, with a BA in Computer Science.

HeartBeam Inc. (NASDAQ: BEAT), closed Wednesday's trading session at $5.18, up 1.1719%, on 52,779 volume with 00 trades. The average volume for the last 3 months is and the stock's 52-week low/high is $19.30 /$.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company"or "Lexaria"), a global innovator in drug delivery platforms ispleased to announce it has demonstrated superior cannabidiol("CBD") blood absorption levels from its patented DehydraTECH-CBD™relative to those of published, pharmaceutical-grade CBD industrycomparators in its recently completed, multi-week human clinicalhypertension study HYPER-H21-4.

In a 2017 randomized clinical trial that evaluated a non-Lexaria,pharmaceutical-grade, plant-derived CBD formulation published by Devinski et. al., an average blood plasma CBD level of 23.0 ng/mL was evidencedafter 22 days (so-called, "steady state"1) of dailydosing at a 5 mg/kg CBD dose level. By comparison, in Lexaria's2022 HYPER-H21-4 hypertension study, a 45.8% higher average bloodplasma level (33.3 mg/mL) was reached at DehydraTECH-CBD's lowestdose level tested of just 3.38 mg/kg, climbing to a blood plasmalevel that was 133.4% higher (53.7 ng/mL) at its highest dose leveltested of 4.46 mg/kg.

The Devinsky publication also examined higher CBD dosing at a levelof 10 mg/kg, evidencing a blood level of 62.1 ng/mL. AlthoughLexaria's HYPER-H12-4 study did not see the need to dose as high as10 mg/kg, the data trend observed at its 3.38 and 4.46 mg/kg doselevels extrapolated linearly to 10 mg/kg would be expected to reacha level of 149.5 ng/mL; a 141% improvement over the Devinsky CBDformulation.

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has a collaborative research agreement with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has filed for patent protection for specific delivery of nicotine, vitamins, NSAIDs, testosterone, estrogen, cannabinoids, terpenes, PDE5 inhibitors (with brand names like Viagra), tobacco and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Wednesday's trading session at $2.45, up 5.6034%, on 26,140 volume with 00 trades. The average volume for the last 3 months is and the stock's 52-week low/high is $1.80 /$4.94 .

Recent News

Knightscope, Inc. (NASDAQ: KSCP)

The QualityStocks Daily Newsletter would like to spotlight Knightscope, Inc. (NASDAQ: KSCP).

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, has announced continued market expansion through securing five new contracts forits Autonomous Security Robot (“ASR”) and Blue Light EmergencyCommunication services across multiple U.S. states. The contractsand deployment locations include a property management group inChicago, a police department in North Carolina, another tribalcasino client in Oklahoma, an airport in New Jersey, as well as aconstruction company in Texas.

The announcement reads, “Knightscope’s expanded product line ishelping its clients protect the places people live, work, study andvisit in many new ways. In addition to this ongoing new growth,Knightscope perseveres with sustained renewals received fromexisting clients, further validating the long-term effectiveness ofits technologies.”

To view the full press release, visit

Knightscope, Inc. (NASDAQ: KSCP), founded in 2013 and based in Mountain View, California, is a leader in the development of autonomous security capabilities targeting to disrupt the $500 billion security industry. Knightscope’s technology uniquely combines self-driving technology, robotics, artificial intelligence and electric vehicles.

Knightscope designs and builds Autonomous Security Robots (ASRs) that provide 24/7/365 security to the places you live, work, visit and study. The company’s client list covers public institutions and commercial business operations, including multiple Fortune 1000 companies to date. These ASRs have been proven to enhance safety at hospitals, logistics facilities, manufacturing plants, schools and corporations. ASRs act as highly cost-effective complementary systems to traditional security and law enforcement officials, providing an additional advantage by continuing to offer uninterrupted patrolling capabilities across the country.

The company’s ASRs have assisted in the arrest of suspects involved in crimes ranging from armed robbery to hit-and-runs. Their machine-embedded thermal scanning capability even aided in preventing the breakout of a major fire. You can learn more about the crime fighting wins at

The company has achieved several milestones since its creation in 2013, including:

  • Establishing itself in a 15,000-square-foot facility located in Mountain View, California, in the heart of Silicon Valley, where Knightscope designs, engineers and builds its technology (Made in the USA)
  • Operating for more than 1 million hours in the field and securing contracts across five time zones, from Hawaii to Rhode Island
  • Raising over $100 million since inception to build its technology from scratch and generating over $13 million in lifetime revenue, validating both the market opportunity and the technology

Growth Capital & Proposed Nasdaq Listing

With backing from more than 28,000 investors and four major corporations and over $100 million raised since inception, Knightscope is poised to be an industry leader in the future of public safety and security.

On December 1, 2021, Knightscope announced the commencement of an offering of up to $40 million of its Class A common stock, with shares to be listed immediately following closing on the Nasdaq Global Market under the ticker symbol ‘KSCP’. The offering is for up to 4 million shares priced at $10 per share. Learn more at

Company Mission – Reimagining Public Safety

Knightscope’s long-term vision has an eye on the greater good. The company’s mission is to make the United States of America the safest nation in the world while supporting the 2+ million law enforcement and security professionals across the country.

Crime has an estimated negative economic impact in excess of $2 trillion annually. As crime is reduced, positive impacts will likely be realized across several aspects of society, including housing, financial markets, insurance, municipal budgets, local business and safety in general.

Knightscope CEO William Santana Li was interviewed by Kevin O’Leary, more commonly known as Shark Tank’s Mr. Wonderful. When asked to explain how the benefits provided by the ASRs outrank a human doing the same job, Li said, “First, just the simple presence of a physical deterrent causes criminal behavior to change. Second, the machines are self-driving cars that patrol all around and recharge themselves. They also generate 90 terabytes of data per year. No human would ever be able to process that. The robots are intended to be eyes and ears for the humans, not a one-to-one replacement.”

The Knightscope solution to reduce crime combines the physical presence of ASRs, sometimes referred to as proprietary Autonomous Data Machines, with real-time onsite data collection and analysis. The ASRs are fitted with eye-level 360° cameras, thermal scanning, public address announcements and various other features that work in tandem with humans to provide law enforcement officers and security guards unprecedented situational awareness.

Those 90 terabytes of data are then formatted in a useable way, so law enforcement can leverage that information and execute their responsibilities more effectively.

Public Safety Innovation

The company’s recurring revenue business model is set up to mimic the recurring societal problem of crime, and it takes into consideration the fact that innovation in the security and public safety industry has been stagnant for decades. Because the traditional practices of the sector have remained unchanged for years, automation has potential to drive substantial cost savings – and significant improvement in capabilities.

Human security guards are one of both the largest expenses and the largest liabilities for companies. Knightscope’s robots are offered at an effective price of $3 to $9 per hour, compared with approximately $85 for an armed off-duty law enforcement officer and $15 to $35 for an unarmed security guard.

This innovation has the potential to drive considerable cost savings. Based on these estimates, manufacturing costs can be recovered as soon as the first year of operation.

Product Offerings

The company has nine patents and a framework of unique intellectual property. Knightscope currently offers a K1 stationary machine, a K3 indoor machine and a K5 outdoor machine. A K7 multi-terrain four-wheel version is in development.

The ASRs autonomously patrol client sites without the need for remote control, providing a visible, force multiplying, physical security presence to help protect assets, monitor changes in the area and deter crime. The data is accessible through the Knightscope Security Operations Center (KSOC), an intuitive, browser-based interface that enables security professionals to review events generated by the ASRs providing effectively ‘mobile smart eyes and ears’. Learn more at

The ASRs and the related technologies were developed ground up by the company and are Made in the USA.

The Robot Roadshow

Knightscope has created the ultimate hybrid physical and virtual event, bringing its Autonomous Security Robot technologies to cities across the country for interactive and in-person demonstrations.

Each roadshow landing is hosted virtually by a Knightscope expert, and visitors can interact directly with each of the company’s ASRs and see the Knightscope Security Operations Center (KSOC) user interface in action. Learn more at

Management Team

Chief Executive Officer William Santana Li is a veteran entrepreneur, a former executive at Ford Motor Company and the founder of GreenLeaf, a company that grew to be the world’s second-largest automotive recycler and is now part of LKQ Corporation (NASDAQ: LKQ).

Chief Client Officer Stacy Dean Stephens brings his experience as a former Dallas law enforcement officer, as well as his skills as a seasoned entrepreneur, to assist on the client acquisition side.

Chief Intelligence Officer Mercedes Soria is an award-winning technologist and former Deloitte software engineer.

Chief Design Officer Aaron Lehnhardt brings over two decades of two- and three-dimensional product and industrial design in modeling and VR to the table, on top of his experience as a senior designer at Ford Motor Company.

Chief Financial Officer Mallorie Burke is a seasoned financial executive and strategic advisor for both private and publicly traded technology companies with a successful track record of mergers & acquisitions, corporate growth and exit strategies, including public listings.

General Counsel Peter Weinberg leverages 30 years of diverse corporate counsel experience, spanning from startups to well-established companies, private and public. He has significant experience training personnel at all levels in critical areas to improve corporate compliance and productivity.

Knightscope, Inc. (NASDAQ: KSCP), closed Wednesday's trading session at $1.64, up 20.5882%, on 750,500 volume with 00 trades. The average volume for the last 3 months is and the stock's 52-week low/high is $1.35 /$27.50 .

Recent News

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF)

The QualityStocks Daily Newsletter would like to spotlight Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF).

We’ve all heard about Santa’s reindeer flying around the world as Santa drops off presents for kids who havebeen nice all year. Have you ever thought about how these animalsfly though? If you guessed psychedelics, you may be right. Somehistorians argue that Father Christmas is a psychedelic mushroom shaman, as shown by his red-and-white suit, which bears resemblance tothe psychedelic fly agaric mushroom. This mushroom, scientificallyknown as Amanita muscaria, is bright red with white flecks. Historical evidence onindigenous psychedelic shamanism in northern Europe and Siberiaeven suggests that the Christmas we know today is based on pagan psychedelic rituals.What isn’t in doubt is that psychedelic substances have been usedfor a long time from time immemorial, and startups such as Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) will be building on this rich tradition of use as they developformulations that can gain FDA approval for use in the medicalsystem.

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation. The company owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms like Reality Sandwich and Delic Radio; Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology; Meet Delic, the premiere psychedelic wellness event; and Ketamine Infusion Centers, one of the largest ketamine clinics in the country.

Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and treatment options to the masses. Its founders helped build the multi-billion-dollar cannabis industry and aim to do the same in psychedelics as it follows a similar path toward legalization. In its quest to advance the new psychedelic renaissance upon us, Delic has become the pioneer in its field, creating an ecosystem of opportunities by investing in cutting-edge ideas.

The Vancouver-based company was formed in 2019 to address the growing interest in psychedelic wellness backed by science. Delic was the ‎first psychedelic umbrella platform. It is currently a trusted source for those interested in ‎psychedelic culture, education, treatments, and more.

While other emerging companies focus on patent medicine and big pharma for substances limited by government regulation, Delic is blazing a unique trail. It identifies ancillary and fully legal opportunities like IP, new media, live events, ketamine clinics (with the ability to offer additional psychedelic treatments once legalized, and large-scale production and brings them under its big tent of resources and reach.

The Big Problems Delic Is Addressing

  • Fifty percent of Americans will meet the criteria for a mental health condition sometime in their lifetime. The FDA has approved psilocybin therapy as a breakthrough therapy for depression.
  • Every 40 seconds, someone in the world commits suicide. Ketamine has been shown to decrease thoughts of suicide significantly. In 2019, the FDA approved esketamine as a fast-acting antidepressant.
  • Traditional palliative care methods do not eradicate end-of-life (EOL) anxiety. LSD and psilocybin have been shown to reduce EOL anxiety for terminally ill patients. Eighty percent of terminally ill patients with psilocybin sessions experienced significant reductions in depression and anxiety.
  • Approximately 50 million people in the U.S. are addicted to some tobacco product. Research shows that psilocybin is helping people quit smoking.

The Delic Ecosystem

The Delic Ecosystem covers three main areas: media, health, and science. The media focus is educating and motivating the masses through a variety of digital platforms, like Delic’s Reality Sandwich digital magazine, a free public education platform providing psychedelic guides, news and ‎culture (1.4+ million page views in 2020 and 54k social media followers across all platforms); Meet Delic, the first-ever psychedelic wellness summit and the premier psychedelic wellness event based in Las Vegas (over 2,000 live attendees and 5,000+ email subscribers); and Delic Radio (over 43 episodes and 100k total streams). Delic has also been featured in numerous media outlets like Forbes, NBC News, The Joe Rogan Experience, Daily Beast, High Times, and The Dr. Drew Podcast.

The focus of Delic’s health operations is the most accessible psychedelic treatments that can help billions of people live happier lives. Delic does this through one of the largest ketamine clinic chains in the country, Ketamine Infusion Centers (KICs), a limited liability corporation formed under the laws of Arizona that runs three ketamine clinics located in Bakersfield, California, and Phoenix, Arizona. Its management team has over 15 years of experience in the clinic and medical space, scaling and operating over 20 clinics, with a plan to open 10 more clinics in the next 18 months. Together, these clinics have overseen 4,000+ treatments delivered to date.

The focus of Delic’s science operations is developing IP and advanced extraction and testing facilities that are the backbone of the legal market. Delic carries this out through Delic Labs, a licensed cannabis and psilocybin research laboratory based in Vancouver. It’s the only entity licensed by Health Canada to exclusively focus on research and development of psilocybin vaporization technology.

Founded by award-winning chemists, Delic Labs focuses on extraction optimization, analytical testing, and chemical process development to advance the cannabis and psilocybin industries. Health Canada gave it a Section 56 Exemption to work with psilocybin compounds, allowing the company to possess and research these products for development and quality control before they hit the market.

Latest Acquisition – Homestead Book Company

On March 4, 2021, Delic announced its acquisition of Seattle-based Homestead Book Company. Homestead is a legacy counterculture distributor of psychedelic media. It’s also the creator of one of the first self-contained psilocybin mushroom grow kits.

The acquisition of Homestead is an exciting one, as it shows how Delic is increasing accessibility to this nascent industry within regulated jurisdictions. Homestead has sold tens of thousands of mushroom kits globally and was one of the earliest distributors for High Times and many other counterculture publications.

The Homestead acquisition allows Delic to increase its product offerings on its website, Reality Sandwich, which recently hit a record for average monthly traffic of over 200,000 unique visitors and over 2.6 million active readers in 2020.

Market Outlook

The psychedelic renaissance is here. Just in time to help address the global mental health crises, plant medicines have the potential to help billions of people live happier lives. Thanks to university-led and FDA-approved studies, North America is leading the way in advancing an industry as psychedelics are becoming accepted globally for therapeutic, medical, and recreational use. Here are some statistics:

  • 32 million people in the U.S. have used psychedelics at least once
  • 17% of all American adults between 21 and 64 have used psychedelics at least once
  • $500 billion is spent in the U.S. every year on prescription drugs
  • $238 billion is spent in the U.S. every year on mental health treatments and ancillary services
  • The anxiety disorder and depression treatment market is estimated at $16 billion
  • $187.8 billion was spent in 2013 on mental health and substance abuse disorders

Management Team

Delic Co-Founder and CCO Jackee Stang was an executive at High Times, a leading counterculture publication that became the voice for the cannabis industry. The monthly magazine had a circulation of over 500,000 copies per issue. Its website attracted 500,000 to five million users each month by 2014.

Likewise, company Co-Founder and CEO Matt Stang was a previous owner and operator of High Times, a position from which he played an instrumental in legalizing cannabis in multiple states and launched the Cannabis Cup in America. After interacting with the cannabis community for two decades, he helped found Delic in 2019 as one of the first psychedelic corporations. He shapes the company’s vision and path using his expertise in branding, marketing, business development, and product viability.

Delic’s VP of Business Development, John Coleman, Ph.D., is a former president of Anandia Labs, a biotech company focused on genetics and analytics. Having experience in both science and business, Dr. Coleman is well-equipped to lead Delic’s business development efforts as it strives to enter new vertical markets.

Zak Garcia is the company’s Chief Marketing Officer. He was the former CMO of Bulletproof Inc., maker of the well-known Bulletproof Coffee brand. Mr. Garcia is a marketing and leadership strategist who helped grow Bulletproof Coffee to over $250 million in revenue.

Delic Holdings Corp. (DELCF), closed Wednesday's trading session at $0.03996, up 8.2927%, on 48,494 volume with 00 trades. The average volume for the last 3 months is and the stock's 52-week low/high is $0.022 /$0.13 .

Recent News

Jupiter Wellness Inc. (NASDAQ: JUPW)

The QualityStocks Daily Newsletter would like to spotlight Jupiter Wellness Inc. (NASDAQ: JUPW).

Jupiter Wellness, Inc. (NASDAQ:JUPW), a wellness company focused on hair, skin, and sexual wellnessannounced today it is rewarding all shareholders of record adigital coupon (NFT) redeemable for a gift package of companyproducts valued at over $179 to drive shareholder engagement andadditional revenue potential. Shareholders of record will be ableto redeem the coupon to try the product first-hand or trade it withother fans globally on Upstream to bring new potential customersinto the community. This news follows the recent approval to liston Upstream and the upcoming listing date of January 10, 2023.

The gift package will have a retail value of $179 and offer anassortment of CBD-infused products, including an 8oz Comfort Cream,50 SPF CaniSun, 55 SPF CaniSun, 30 SPF CaniSun Continuous Spray,Acai Lip Balm, Peppermint Lip Balm, and their original Healing LipBalm. In addition to the CBD products, investors will also receivea sample bottle of the company's NoStingz jellyfish preventionsunscreen.

Jupiter Wellness Inc. (NASDAQ: JUPW) is a diversified company that supports health and wellness by researching and developing over-the-counter (OTC) products and intellectual property. The company has a robust and growing portfolio of granted and pending patents to protect its proprietary products.

Jupiter Wellness’s product pipeline, backed by clinical research to ensure efficacy, addresses a range of underserved conditions. The company’s revenue is generated through a combination of OTC and consumer product sales, contract research agreements, and licensing royalties.

Jupiter Wellness was formed in 2018 and is headquartered in Jupiter, Florida.

Products with Purpose

Jupiter Wellness’s product pipeline currently targets a variety of indications with underserved needs. These include:

  • Hair Loss – Jupiter Wellness’s Minoxidil Booster is a topical treatment that’s been clinically shown to increase the enzymes needed for minoxidil to work by up to 7x over a two-week period. The product has been licensed to Taisho, a $2.6 billion revenue company and Japan’s leading seller of minoxidil products, which expects to launch it commercially in 2023. The product is licensed to India-based Cosmofix Technovation Pvt. Ltd. and Sanpellegrino Cosmetics, and additional licensing opportunities are being pursued.
  • Psoriasis & VitiligoPhotocil safely and effectively permits phototherapy treatments at home by blocking harmful radiation and permitting the passage of therapeutic UV radiation. The product has been licensed abroad and is currently being launched commercially in India by Eris Oaknet Healthcare and Cosmofix Technovation under the brand name PhotoFirst. The product is also available in the U.S., and the company is working to find new partners in dermatology for expanded distribution.
  • Jellyfish Protection SunscreenNoStingz is a topical protection from jellyfish, sea lice, and UVA/UVB rays. It provides an effective barrier against the stinging mechanism of jellyfish cnidocytes, preventing the delivery of venom to the victim. NoStingz is currently available online through Amazon and Walmart, as well as in select stores.
  • EczemaJW-100 is a pre-revenue topical treatment for atopic dermatitis (eczema). In prior studies, JW-100 cleared or reduced eczema symptoms following 2 weeks of use. Results suggest that JW-100 may potentially prove superior to existing prescription drugs. It is currently being evaluated in a Phase 3, double-blind, placebo-controlled multicenter trial.
  • BurnsJW-300 is a pre-revenue topical treatment for first-degree burns and sun exposure. In prior studies, JW-300 was shown to significantly lower the incidence of burns in patients exposed to UV radiation. It is currently being evaluated for sale as an “after sun” consumer product.
  • Cold SoresJW-400 is a pre-revenue topical treatment of herpes labialis (cold sores). A phase 1, double-blind, placebo-controlled investigational study is currently being planned for JW-400.
  • Sexual WellnessJW-500 is a pre-revenue topical treatment for female libido loss. In clinical studies, the topical formulation improved nipple sensitivity and alleviated associated sexual problems. Jupiter Wellness plans to file for a pre-IND meeting with the U.S. FDA within the next 12 months and intends to seek Orphan Drug Designation.
  • COVID-19-Induced TinnitusJW-600 is currently being evaluated in a triple-blind clinical study. Up to 15% of patients recovering from COVID-19 have experienced post-acute COVID-19-induced tinnitus

Management Team

Brian John is the CEO of Jupiter Wellness. For the past 20 years, he has been an investor and advisor to companies around the globe. He is the founder of a successful financial consulting firm specializing in helping emerging growth companies and has worked with hundreds of companies in dozens of countries over the last 25 years. Mr. John also serves on the board of directors of The Learning Center at the Els Center of Excellence – a school for children with autism in Jupiter, Florida.

Doug McKinnon is the CFO of Jupiter Wellness. His 35+ year professional career includes financial, advisory, and operational experience across a broad spectrum of industry sectors, including oil and gas, technology, cannabis, and communications. He has served in C-Level positions in both private and public sectors, including as chairman and CEO of an American-stock-exchange-traded company; as VP – Chief Administrative Officer of a $12-billion-market-cap Nasdaq-traded company; as CFO of several publicly-held U.S., Canadian and Australian companies; and as CEO/CFO of various other private enterprises.

Dr. Glynn Wilson is the Chief Scientific Officer of Jupiter Wellness. He brings to the company an extensive background of success in corporate management and product development with tenures in both multinational and start-up biotech organizations. He was formerly Head of Drug Delivery at SmithKline Beecham Pharmaceuticals; Research Area Head in Advanced Drug Delivery at Ciba-Geigy Pharmaceuticals; and Founder, CEO, and Chairman of TapImmune Inc., which became Marker Therapeutics through a merger. At TapImmune, he licensed cancer vaccine technology platforms and established the clinical pipeline.

Jupiter Wellness Inc. (NASDAQ: JUPW), closed Monday's trading session at $2.05, up 3.0151%, on 73,251 volume with 375 trades. The average volume for the last 3 months is 57,207 and the stock's 52-week low/high is $1.04999995/$5.63000011.

Recent News

Flora Growth Corp. (NASDAQ: FLGC)

The QualityStocks Daily Newsletter would like to spotlight Flora Growth Corp. (NASDAQ: FLGC).

Decades after California legalized medical cannabis and launched anindustry that would soon be worth billions of dollars in revenue, interstate cannabis is still virtually nonexistent. But eventhough America’s state-legal cannabis industry now employs hundreds of thousands of people and generates billions of dollars in taxes, there is little to no interstate commerce between states withlegal markets. This is partly because most of these states includedstipulations in their regulator frameworks that prevented them from trading with other states. As a result, cannabis producers cannot ship their products acrossstate lines or source cannabis-related raw materials from otherstates. However, analysts familiar with the matter say that this may soon change if a lawsuit against Oregon’s cannabis law is successful. If thelawsuit against Oregon officials is successful, it could encourageother states to fight for the approval of interstate cannabis tradethrough their respective courts. If the courts sanction interstatecommerce involving cannabis, entities such as Flora Growth Corp. (NASDAQ: FLGC) would probably have to rethink their approach to expanding theirfootprint across the country.

Flora Growth Corp. (NASDAQ: FLGC) is an internationally focused cannabis brand builder that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions, including cosmetics, hemp textiles, and food and beverage. Flora Growth operates one of the largest outdoor cultivation facilities in the world with an aim of marketing a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, the company creates premium products that help consumers restore and thrive.

Flora Growth completed the first traditional cannabis IPO on Nasdaq in May 2021. Although currently headquartered in Toronto, Ontario, with plans to relocate its head office to Miami, Florida, the company’s base of operations is in Colombia, where it has built an extensive distribution network that includes Colombia’s largest distributors.

Currently, Flora Growth is organically growing market share for its existing brand portfolio (pharmaceuticals, textiles, cosmetics, and food & beverage) while seeking revenue-generating acquisitions that offer an accretive distribution network to amplify revenue growth.

Existing Brand & Product Portfolio

Flora Growth’s portfolio spans a number of verticals – each with a thoughtful brand designed to resonate with its intended end consumer. In line with the company’s mission, each brand prioritizes natural ingredients and value-chain sustainability.

Flora Lab S.A.S

Flora Lab is the company’s GMP certified manufacturing and R&D center focused on producing pharmaceuticals, cosmetics, and nutraceuticals for domestic and international markets. Its offerings include product lines that are private label, white-label, and custom formulas.

Through Flora Lab, Flora Growth has relationships with 1,500+ distribution channels, manufactures 63+ OTC products registered with INVIMA (Colombia National Food and Drug Surveillance Institute), and holds multiple GMP certifications enabling international export in an effort to leverage Flora Lab’s capacity to produce a wide range of CBD-infused products.

Flora Beauty

Flora Beauty is the company’s CBD beauty and cosmetics division founded by fashion and beauty industry icon Paulina Vega. Its current offerings include two CBD skincare brands targeting the U.S. and Latin American markets – MIND NATURALS and AWE. These lines exemplify Flora Growth’s socially conscious approach to business.

Currently, Flora Beauty products are offered globally through e-commerce, as well as through Falabella’s 111 retail locations across Latin America. The company is in negotiations with major department stores to launch the line in the U.S. and is also exploring opportunities in the U.K. and other European markets.

KASA Wholefoods

KASA Wholefoods is a Colombian manufacturer of food and beverages leveraging responsibly sourced exotic fruits from the Amazon. KASA has a $10 million+ distribution agreement with Tropi, Colombia’s largest food distributor, which has 130,000+ distribution points across the country.

Mambe, KASA’s leading brand, is already offered through over 980 distribution points across Colombia. Flora Growth expects this network to grow to over 1,200 distribution points in 2021, including one of Colombia’s largest coffee chains, Tostao Café & Pan.

Hemp Textiles & Co.

Through its Hemp Textiles division, Flora Growth intends to utilize its large land package and cultivation infrastructure to capture market share in the rapidly growing hemp industrials segment.

The company’s first brand through this division, Stardog Loungewear, offers a line of comfortable loungewear made from natural, organic materials. Stardog has been distributing globally through e-commerce and brick and mortar channels in Bogota since fall 2020, and the company intends to open U.S. brick and mortar locations in 2021.

Accretive M&A

Flora Growth is targeting transactions to complete the supply chain via key infrastructure to enhance its global distribution with the aim to compete on low-cost, high-quality inputs paired with premium brands that create business lines with robust margins.

To date, Flora has announced two major transactions.

Koch & Gsell (Acquisition)

  • Amplify CPG portfolio’s revenue growth through leading brand, Heimat, currently with TTM revenues of $7.6 million.
  • Leverage Koch &Gsell’s distribution network of 2,500+ stores to introduce Flora to the Swiss, European and Asian markets.
  • Bring patented hemp cigarette manufacturing technology into new markets utilizing Flora’s high-quality cannabis.

Hoshi International (Investment)

  • Equity Investment of €2 million into Hoshi to establish Flora as a preferred supplier to two EU processing facilities.
  • Opens gateway for Flora Growth’s cannabis through international distribution agreements in the EU and U.K.
  • Hoshi’s experienced team and increased access to the EU cannabis market to serve as a catalyst for revenue growth.


Key to Flora Growth’s expansion efforts is its cultivation strategy. The company’s Cosechemos farm, located in Bucaramanga, Colombia, is currently licensed to cultivate 247 acres of cannabis. Through three successful pilot crop plantings, the location has demonstrated a production cost of just $0.06/gram. For comparison, the average cost of North American cannabis (based on 2019 figures from Aphria, Tilray, Sundial, and Aurora) equates to roughly $1.89/gram.
Flora Growth is uniquely positioned to capitalize on Colombia’s favorable growing conditions, low-cost infrastructure, and affordable local workforce as it looks to ramp up its cultivation efforts moving forward.

Leadership Team

Bernard Wilson is the Chairman of Flora Growth. A senior financial professional, Dr. Wilson is the former Vice-Chairman of PricewaterhouseCoopers LLP and is the Chairman of the Founders Board of the Institute of Corporate Directors. He has also served as Chairman of the Canadian Chamber of Commerce; Chairman of the International Chamber of Commerce – Canada; and Member of the Canada/U.S. Trade Committee. Dr. Wilson draws on this experience to ensure Flora Growth adheres to effective corporate governance practices.

Luis Merchan is the company’s President and CEO. He is a proven executive with over a decade of experience in enterprise sales management, corporate strategy, merchandising and expense management, and customer experience. Mr. Merchan previously served as Macy’s Inc.’s Vice President of Workforce Strategy and Operations, where he managed the enterprise’s multi-billion-dollar P&L expense line for the entire 540 store portfolio. Throughout his tenure at Macy’s, he led various sales and marketing initiatives, including the B2B corporate sales team that was responsible for $160 million in annual revenue. Mr. Merchan obtained his Bachelor of Industrial Engineering from Pontifical Xaverian University in Bogota, Colombia, and his MBA from McNeese State University. He also holds a Graduate Certificate in Marketing Management from Harvard.

Juan Manuel Galan is a Strategic Advisor to the Flora Growth management team. Mr. Galan currently serves as a senior consultant to The World Bank. He is a politician and former senator of Colombia, serving three terms from 2006 to 2018 as a member of the Colombian Liberal Party. He is also a former professor at the University of Rosario and holds more than 20 years of journalistic, academic, governmental and parliamentary experience. During his time as a senator, Mr. Galan was a key leader, with 29 bills and 27 debates on political control, and 17 laws to his name. The most relevant of those laws was authoring the medical cannabis law that resulted in the legalization of medical cannabis in Colombia.

Stan Bharti is a Director of Flora Growth. Mr. Bharti currently serves as Executive Chairman of Forbes & Manhattan. He has more than 30 years of professional experience in business, finance, markets, operations and more, with a focus on the resource and technology sectors. To date, Mr. Bharti has amassed over $3 billion worth of investment capital for the companies with which he has worked and their shareholders. He is a Professional Mining Engineer and holds a master’s degree in engineering from Moscow, Russia, and University of London, England.

Javier Franco is the company’s VP of Agriculture. Mr. Franco is a master horticulturist with more than 25 years of experience in the design, implementation, and management of cultivation and propagation facilities of more than 30 species of cut flowers in Latin America. He completed his agricultural studies at Zamorano University in Honduras and later at an International Exchange Program at Ohio State University. Mr. Franco has directed technical, commercial, and research groups in the cut flower, fruit and vegetable markets in Latin America and has participated in the commercial development of new technologies applied in agribusiness. He has also led the agri-management of organic crops and certifications of Good Agricultural Practices.

Flora Growth Corp. (FLGC), closed Wednesday's trading session at $0.26, up 6.6448%, on 376,245 volume with 00 trades. The average volume for the last 3 months is and the stock's 52-week low/high is $0.23 /$2.38 .

Recent News

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F)

The QualityStocks Daily Newsletter would like to spotlight Hillcrest Energy Technologies Ltd. (OTCQB: HLRTF).

Hillcrest (CSE: HEAT) (OTCQB: HLRTF), a clean technology company developing transformative powerconversion technologies and control system solutions fornext-generation electrical systems, today issued a recap of thesignificant progress achieved by the company during the year. “2022has been a tremendous year for Hillcrest, as the company met orexceeded every milestone we set out to achieve. We are proud of theincredible progress made thus far,” said Hillcrest CEO Don Currie.“We entered the year with a proof of concept for our coretechnology, the Hillcrest ZVS inverter technology, and progressedthrough design, commissioning and finally completion of our firstcustomer-centered product. Our technical team has delivered atevery level and excitement is building around even biggerexpectations in 2023.”

To view the full press release, visit

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) is a clean technology company based in Vancouver, British Columbia, engaged in developing high-value, high-performance power conversion technologies and digital control systems for next-generation powertrains and grid-connected renewable energy systems.

From concept to commercialization, Hillcrest invests in the development of energy solutions that power a more sustainable and electrified future. Hillcrest power inverter technology helps produce efficiencies in electrification and maximize the performance of electric systems, including electric vehicles (EV), motors and generators.

The company offers a flexible, single-inverter architecture that can be applied at nearly every stage of the electrification ecosystem, from renewable energy generation through the charging and operation of an EV, to provide full-cycle efficiency and performance improvements.

As momentum to electrify and decarbonize energy systems accelerates, Hillcrest believes the power inverter is increasingly emerging as a key component. While system cohorts such as battery packs, PV panels and electric motors are often in the spotlight, the inverter holds the key to unlocking efficiency and performance improvements.

Hillcrest power inverter technology is:

  • REVOLUTIONARY: high-efficiency inverter technology has the potential to revolutionize how motors respond and how efficiency is gained.
  • AGILE: able to deliver and deploy high-efficiency inverter solutions purpose-designed to meet specific customer needs.
  • INNOVATIVE: technology-forward, clean-energy experts who are focused on advancing and optimizing efficient alternative energy use across all electric vehicle and charging platforms.
  • A MARKET LEADER: a next-generation technology provider to the automotive industry’s top suppliers and manufacturers.

Technology & Applications

Hillcrest’s first application for its inverter technology – a 250 kW|800V Hillcrest SiC high efficiency traction inverter – is focused on the growing EV market. Hillcrest technology eliminates traditional design trade-offs faced across the power industry – deploying higher switching frequencies has historically meant a greater increase in losses, lower system efficiency and higher heat. Through a combination of hardware and software expertise, Hillcrest enables power applications to leverage higher switching frequencies AND

  • Realize improved power system performance and reliability
  • Operate at higher power levels without compromising efficiency

The expected benefits of Hillcrest’s traction inverter have been confirmed via testing and shared in a technical white paper, published in April 2022, that confirmed the following results:

  • Significant efficiency gains – 99%-plus inverter efficiency
  • Increased power density targeting 50kW/L+
  • Significantly increased motor efficiency
  • Lower stress on mechanical and electrical parts, enhancing reliability
  • Improved thermal management

Hillcrest has also filed a patent for an enhanced powertrain solution that offers the potential to simplify EV charging and redefine how the industry envisions charging infrastructure. The company believes the most exciting benefit of the enhanced powertrain solution is the ability to eliminate the onboard charger and booster from an EV, as well as faster, anywhere charging including direct DC, wireless, and bidirectional charging across current and future power levels. Hillcrest sees this as a true EV charging game changer.

The company’s technology applies to nearly every clean energy industry segment:

  • Wind power – an inverter is deployed at a wind turbine generator to convert the AC output, with at least one additional inverter used to deliver the power to the grid/battery.
  • Solar power – an inverter is used to convert the DC output from the photovoltaic panels into the AC power that flows to the grid/battery/home.
  • Energy storage – an inverter is deployed to convert the DC output from the storage system or batteries to the AC power that flows to the grid/home/EV.
  • EV fast chargers – an inverter converts the AC input from the grid/storage system to the DC output needed to charge an EV’s battery.

Market Outlook

According to an April 2022 market analysis by Vantage Market Research (VMR), the global power inverter market is expected to reach a value of $95 billion by 2028, driven by increasing demand for EVs, energy generating wind turbines and solar-powered photovoltaic systems. That jump is forecast from an estimated $70.5 billion market value in 2021 and represents a compound annual growth rate of more than 5%.

According to the VMR report, many governments in countries around the world are supporting alternative options for efficient and nonpolluting energy generation. This has boosted demand for wind energy and solar energy systems. Hillcrest is aiming to capture a share of this future market growth across nearly every segment of the clean energy industry.

Management Team

Don Currie is the founding CEO of Hillcrest Energy Technologies. He has led the company’s successful transition from fossil fuels into clean energy technologies. Earlier in his career, he held various senior level positions, including director, officer and vice president of corporate communications with Enhanced Oil Resources Inc., an oil and gas exploration and production company based in Houston. Prior to that, he worked in other private and public ventures spanning the mining, gaming and technology sectors.

Jamie L. Hogue is the COO of Hillcrest. She brings more than two decades of progressive policy leadership, economic analysis and organizational development experience to Hillcrest. She builds collaborative processes and solutions that drive growing organizations toward a more resilient future. She previously served as the director of operations for Arizona State University’s Ten Across initiative – a compelling observatory positioned on the front lines of economic, social and climate change. She earned a master’s degree in public administration and a bachelor’s degree in economics from Arizona State University.

Ari Berger is Chief Technology Officer at Hillcrest. He brings over a decade of commercial experience with a track record of deploying new electrification technologies and go-to-market strategies. In 2015, he founded NIG Systems Ltd. in Israel, which specializes in custom high performance control systems design. Prior to this, he previously worked for Bental Industries, a leading motor manufacturer. He holds a master’s degree in system control engineering from the Technion – Israel Institute of Technology.

Raj Clair is CFO at Hillcrest. She is a CPA who began her career at Deloitte and has served in advanced finance positions in the energy and resources sector. She has been responsible for reporting, audits and internal controls, as well as working on budgeting and forecasting. She has worked with various publicly listed companies, including SEC registrants, and has both Canadian and U.S. experience. She holds a bachelor’s degree in accounting from Simon Fraser University.

Hillcrest Energy Technologies Ltd. (NASDAQ: HLRTF), closed Wednesday's trading session at $0.0777, up 3.6%, on 15,100 volume with 00 trades. The average volume for the last 3 months is and the stock's 52-week low/high is $0.07 /$0.1724 .

Recent News

REZYFi, Inc.

The QualityStocks Daily Newsletter would like to spotlight REZYFi, Inc.

As other states join in legalizing marijuana post-pandemic,teenagers’ use of cannabis has remained stable through 2022. Thedirector of the National Institute on Drug Abuse (NIDA), NoraVolkow had earlier deduced that the drop in teenage substance abuse was because of the COVID social restrictions. There was an expectation of anupsurge in substance use post-pandemic, but that was not the case.The previous month/daily marijuana intake among the senior highschool kids was unchanged.“Use of cannabis, among the senior high schoolers, has remaineda plateau,” an officer from NIDA said. It is also reported that cannabisvaping among 8th graders was at 6%, 15% among 10th graders and20.6% among 12th graders by 2021, signifying a neutral prepandemictrend. Post-pandemic (2022) usage was slightly higher thanprepandemic usage among the 10th graders. These findings fromfederally funded studies show that the marijuana industry has beentaking a lot of needless flak and part of what it needs is fundingfrom not only entities such as REZYFi Inc. but also traditional banks so that the sector can grow and servemore people by providing jobs and gathering taxes without puttingteens in significant danger.

REZYFi, Inc. is a cannabis mortgage bank servicing the needs of both traditional and non-traditional consumers and businesses. Its target markets include licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing and project-specific financings, such as solar installations and real estate development projects.

Headquartered in Miami, Florida, REZYFi operates through two wholly owned subsidiaries – REZYFi Lending, which primarily addresses emerging real estate-related financing opportunities, and ResMac Inc., the company’s traditional mortgage origination, correspondent and servicing operation. REZYFi is currently licensed in 34 U.S. states, with plans to expand to all remaining states later this year.

REZYFi is positioned as one of first cannabis mortgage bankers in the U.S., while most traditional lenders are still reticent to serve the state-licensed cannabis industry.


REZYFi Lending

REZYFi Lending leverages a wide network to offer options such as 15- and 30-year fixed-rate loans, FHA loans, VA loans, reverse mortgages, jumbo loans and adjustable-rate mortgages.

Looking ahead, the company expects increased funding in marketing and loan agents to drive significant origination growth over the next two years, further supported by the planned launch of a high-margin cannabis division later this year.

ResMac Inc.

ResMac has been in operation for 13 years, having closed more than 20,000 loans for more than 15,000 clients. The company expects to accumulate $285 million in retail origination in 2023, alongside $250 million in wholesale origination for the same period. ResMac is further targeting $600 million in origination through its mortgage correspondent operations for 2023.

Through its ResMac subsidiary, REZYFi operates as a direct lender and originator of residential mortgages, with active mortgage correspondent and mortgage servicing operations. Through its correspondent segment, ResMac primarily purchases and aggregates residential mortgages from trusted third-party originators.

The company intends to harvest the database of customers within its mortgage servicing operations as an essential source of additional growth, especially relative to the new alternative residential loan programs being offered.

Corporate Strengths

  • Experience – REZYFi is led by a seasoned management team with significant expertise spanning a wide range of real estate and financing subsectors. The team also has extensive experience in the cannabis and hemp marketplace, which the company intends to leverage as it navigates the changing landscape of the cannabis industry while sourcing the best opportunities in the sector.
  • Network of Independent Brokers – Over the past five years, REZYFi has developed an extensive network of independent mortgage-related brokers and licensed loan officers. The company is currently training the network members on its new service offerings, with many already launching sales efforts. REZYFi believes this network will be a vital asset moving forward as other firms in the sector terminate relationships in the face of slowing mortgage business in a rising interest rate environment.
  • Proprietary Technology – REZYFi has invested heavily in designing, building and implementing proprietary automated/machine learning technology to shorten loan processing timeframes and increase efficiencies, allowing it to operate its legacy business at staffing levels meaningfully below those of its competitors.

Market Overview

REZYFi’s diversified approach to the real estate lending sector positions it to capitalize on growth in multiple verticals in the years to come.

In the first quarter of 2022, lenders issued 2.71 million residential loans, with the average balance for a first mortgage climbing to a record high of $298,324 in 2021, according to the Mortgage Bankers Association. This trend is expected to continue, with Freddie Mac forecasting a 10.4 percent increase in home prices in 2022 and a 5.0 percent bump in 2023. Growth prospects in the cannabis industry paint a similar picture.

The National Association of Realtors® issued a report in April 2021 examining the correlation between cannabis legalization and real estate demand. In states where prescription and recreational cannabis use is legal, more than a third of surveyed agents reported an increase in demand for warehouses. Likewise, 23 percent of those surveyed reported an increase in demand for storefronts, and 28 percent observed increased demand for land. As other states look to join the 19 that have embraced full cannabis legalization, this rising demand could create an opportunity for REZYFi’s cannabis-focused initiatives.

In total, an analysis by market research firm Business Research Insights projects the global loan servicing market to reach a value of nearly $1.5 billion by 2028, up from $680.8 million in 2021. Those figures represent a CAGR of 11.0 percent during the forecast period of 2022-2028.

Management Team

John Vu, Esq., is CEO of REZYFi, Inc. He has more than two decades of experience in the mortgage and commercial banking industry. He has filled many senior and executive management positions in high-producing mortgage banks, including C-level assignments. He has also served as general counsel for a nationally associated commercial bank. Mr. Vu brings considerable cannabis industry expertise to REZYFi. He has served as a corporate attorney to multiple cannabis cultivators, manufacturers and retailers.

Ji Ji Zhang, Esq., is CFO of REZYFi, Inc. He is a multifaceted entrepreneur who owns a law firm, a portfolio of hotels and a high-producing mortgage bank. Mr. Zhang is also an investor in the development of a cannabis business park. He brings more than five years of experience in mortgage banking to REZYFi, having developed Freddie Mac and HUD licenses and amassed a managed portfolio valued at over $300 million.

Kevin Heckemeyer is President of REZYFi, Inc. He has more than 25 years of experience in mortgage banking. He has built and sold several high producing mortgage businesses. In his current roles with ResMac, he is responsible for production and operations.

Spencer Dang is Chief Credit Officer of REZYFi, Inc. He has more than a decade of experience in mortgage operations. He is a direct endorsement underwriter for HUD and has specialized in non-QM underwriting. Under his watch as an underwriter, he has never had a single repurchase.

Recent News


Cub Crafters Inc.

The QualityStocks Daily Newsletter would like to spotlight Cub Crafters Inc.

CubCrafters, the leading designer and manufacturer of light-sport,experimental and Part 23 certified backcountry aircraft, hasannounced its acquisition of Summit Aircraft Skis, including thecompany’s design and manufacturing assets, unique patents andrelated intellectual property, from the Sandpoint, Idaho-basedSummit Aircraft Corporation. Favored by Carbon Cub owners, SummitAircraft Skis are also preferred by the owners of many other typesof non-CubCrafters manufactured backcountry capable aircraft. Theunique ski design enables pilots to quickly and easily configuretheir aircraft to fly to many remote and primitive areas otherwiseinaccessible in winter when runways are not maintained. “We arevery excited and pleased to welcome Summit’s customers and productsinto our family here in Yakima,” said Patrick Horgan, CubCrafterspresident and CEO. “It has been a joy for our team to work togetherwith Mike Custard, Summit’s founder, to coordinate a smooth skimanufacturing transition. Adding Summit Skis to the CubCraftersproduct lineup allows us to better meet our customers’ needs andadds a new profit center. We see a great potential for growth withthe Summit brand that we want to be a part of going forward.”

To view the full press release, visit

Cub Crafters Inc. (typically styled CubCrafters) is an OEM aircraft manufacturer based at McAllister Field Airport in Yakima, Washington. The company was founded in 1980 to build parts and supplementary type certificate (STC) improvement modifications, which were used to establish it as the preeminent center for rebuilding the classic Piper PA-18 Super Cub light aircraft. CubCrafters went on to advance the market with its own, newly manufactured aircraft models and holds an approved Federal Aviation Administration (FAA) Production Certificate. Yakima-based operations include an engineering design-test-certification center, aircraft parts and assembly production facilities, and an MRO maintenance service and overhaul facility.

The first newly manufactured aircraft by the company, the CC18-180 Top Cub, was Federal Aviation Administration (FAA) type certified in December 2004. The Top Cub was also granted type certificates (TC) by Transport Canada in July 2008, followed by Australian certification in August of that same year. With the FAA’s release of the new Light Sport Aircraft (LSA) class, CubCrafters created a brand-new model in 2008, the CC11-100 Sport Cub, similarly based on the original Piper J-3 Cub’s appearance, which it validated to ASTM international standards as an LSA. This model advanced to become known as the Carbon Cub, the bestselling LSA of all time in the U.S.

CubCrafters focuses on four main product lines, including the Carbon Cub SS, Carbon Cub FX, XCub, and the Top Cub under license. Some models are built to be lightweight and powerful for quicker flights, while others are built for longer missions in unforgiving backcountry environments.

CubCrafters has a service and overhaul facility for PA-18 Super Cubs and other Cub derivative designs at its Yakima headquarters. The company sells aircraft kits as well as finished aircraft.


The Carbon Cub is available in three variants: Carbon Cub SS (production Light Sport Aircraft), Carbon Cub FX (an innovative Builder Assist E/A-B aircraft) and Carbon Cub EX (E/A-B aircraft kit). Carbon Cub has been designed for off-airport operation with a powerful engine, strong lightweight airframe and nimble low-speed manners. The Carbon Cub has taken the fundamentally superior design of the Piper Super Cub and reinvented it using 21st century materials and computer-aided design. Superior engineering results include the Carbon Cub having 50% fewer parts and weighing more than 300 pounds less than a similarly equipped Super Cub. Now in its third generation of innovation advancements, there are over 1,000 Carbon Cubs flying.

The CubCrafters CC19-180 XCub, FAA Certified and introduced in June 2016, is supplied complete and ready-to-fly. The XCub is a further scaled development of the CubCrafters Carbon Cub, which the company continues to supply, but with higher performance and incorporating more structural carbon fiber. The XCub was developed over a six-year period and not publicly announced until FAA TC had been completed and issued. The process was completed organically using company resources and did not involve any venture capital, loans nor any advanced customer deposits. XCub is built on a wholly original fuselage design. The CNC-milled 4130 chromoly steel frame meets the latest FAA Part 23 certification standards for 2,300-pound gross weight aircraft. XCub’s useful load is as high as 1,084 pounds. Current Part 23 certification requirements ensure this is the strongest Cub ever produced. It can fly farther, providing greater comfort. It is an airplane that has taken the best from the past and, using the very latest in design, material and manufacturing technology, has established a new standard.

The XCub was approved by the FAA for seaplane operations in December 2017. That same month, EASA approved the XCub design and issued a new type certificate. Four international type certificates have been gained: EASA Dec-2017, Canada Feb-2018, Japan April-2018, and Australia Aug-2018.

CubCrafters increased the horsepower of the XCub line in 2019, offering two new models: the CC19-215 FAA Certified version and the CCX-2300 Builder Assist, both powered by the new CC393i 215 HP engine built by Lycoming.

In December 2021, CubCrafters gained FAA Certification of a new nose wheel version of the XCub, branded the NXCub.

Market Overview

According to a 2022 analysis by research firm Expert Market Research (“EMR”), the global ultralight and light aircraft market was valued at $7.63 billion in 2021. The EMR report says the market is expected to grow at a CAGR of 4.5% in the forecast period of 2022-2027 to reach a value of $9.93 billion. Ultralight and light aircraft are small aircraft with on-board pilot (and perhaps passengers) designed for use in recreation, sports, pilot training, aerial surveys, mapping, research and agriculture, humanitarian backcountry access, and special military missions, as well as business and personal travel.

CubCrafters currently enjoys a dominant market share of the rugged adventure airplane market.

Management Team

Patrick Horgan is President and CEO at CubCrafters. Before he assumed that role, he was the company’s Vice President/Director of Engineering & Product Development for three years, when he led the FAA Part 23 type certificate approval and production certificate approval of CubCrafters’ newest flagship, the XCub. Mr. Horgan also directed the breakthrough certification that authorized the use of experimental avionics in FAA-certified production aircraft, a first in aviation history. He brings over 30 years’ aircraft development and manufacturing experience in general aviation, commercial, and military industries. Prior to service at the company, he was the General Manager at WACO Classic Aircraft Corporation in Battle Creek, Michigan, and was the commercial aircraft manager of the Boeing 777 wheel and brake program for Goodrich Aerospace in Troy, Ohio. He was also a designer on the F/A-18 Super Hornet at McDonnell Douglas (now Boeing) in St. Louis, Missouri. Mr. Horgan holds degrees in aeronautical and astronautical engineering from the University of Illinois, and a certificate in Disruptive Strategy from Harvard Business School. He serves as a member of the Board of Directors of the General Aviation Manufacturers Association and on ASTM aircraft standards committees.

Brad Damm is Vice President at CubCrafters. He has overseen CubCrafters’ sales, marketing, and brand management operations since 2018. Since first joining CubCrafters in 2013, Mr. Damm has served as Factory Direct Sales Manager, the Director of Sales Support, the Global Director of Sales, and the Vice President of Sales and Marketing. During his tenure, the company has seen new sales records year after year across all of CubCrafters new aircraft and kit product lines, and the CubCrafters brand has risen to new levels of awareness and respect with aviation consumers worldwide. Prior to joining the company, he served for over 10 years as the Business Development Manager for one of the largest commercial concrete contractors in the Pacific Northwest, driving the sales and revenue growth that allowed the company to expand from a few dozen to hundreds of employees.

Rick Johnson is the Director of Finance at CubCrafters and has been with the company since 2017. He has 27 years of previous experience as controller and CFO for fruit packing and timber operations in the Pacific Northwest. He holds a Bachelor of Science in Business Administration from Central Washington University.

Christopher Matus is Production Manager at CubCrafters and joined the company in 2011. Before taking that post, he held positions as Fabrication Plant Manager, Machine Shop Manager and CNC Machinist for the company. He has also served as a Combat Engineer in the Washington Army National Guard, deploying to Afghanistan and to natural disasters including the 2014 Oso Mudslide.

Justin Jansky is the Administrative Manager at CubCrafters. He joined the company in 2015 and has a demonstrated history of successful collaboration on major FAA type certification projects in the general aviation industry, specifically under 14 CFR Parts 21 and 23. He is responsible for process management, document control, facilitating FAA certification processes, coordination with FAA delegates and documenting compliance testing. He holds a bachelor’s degree in technology and applied design.

Recent News


EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF)

The QualityStocks Daily Newsletter would like to spotlight EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF).

Alberta Research Council estimated Canada’s RNG productionpotential equivalent to 1,200 billion cubic feet annually, equal to~1/3 of 2017 natural gas consumption

EverGen Infrastructure is leading the trend towards RNG,owning/operating 4 projects in western Canada with expansion intoOntario through 50% ownership in a large-scale project

Flush with cash, EverGen is expanding aggressively, withexpectations for core projects to generate a range of $50-$60million in annual revenue

Canada is stepping up its game in a bid to meet its goal of netzero emissions by 2050, a benchmark that has become the target ofmany countries worldwide. Currently, over 140 countries haveofficially set targets or are considering a net zero by 2050commitment. In June 2021, Canada passed the Canadian Net-ZeroEmissions Accountability Act, enshrining its vision into law,promptly following that in July by lowering its mid-term goal toemissions levels of 40-45% of 2005 levels by 2030, versus a priormark of 30 percent. The regulatory atmosphere and social awarenesssituation couldn’t be better for companies like EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF), which is aggressively expanding nationwide with its RenewableNatural Gas (“RNG”) infrastructure platform.

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) is developing Canada’s Renewable Natural Gas Infrastructure Platform, starting on the west coast in British Columbia. The company is combating climate change and helping communities contribute to a sustainable future by acquiring, developing, building, owning and operating a portfolio of renewable natural gas (RNG), waste-to-energy, and related infrastructure projects.

While EverGen is currently focused on British Columbia, its continued growth is expected across other regions of North America. RNG is produced differently than conventional natural gas, without drilling wells. RNG is derived from biogas, which is captured from decomposing organic waste in landfills, food waste, agricultural waste matter and wastewater from treatment facilities. This waste feedstock is supplied to an anaerobic digester which contains bacteria that breaks down organic matter in the absence of oxygen. The resulting biogas is captured and cleaned to create carbon neutral or carbon negative RNG to be used by the existing North American gas pipeline grid. By capturing these emissions and transforming them into RNG, then combusting into CO2, the overall greenhouse gases (GHG) impact is materially less potent than allowing natural decomposition to release methane into the atmosphere. Liquid and solid digestate matter is a byproduct of the RNG production process and is used as fertilizer and in other applications.

EverGen operates three projects in British Columbia. The company was incorporated in 2020 and went public in 2021, with its common shares listed on the TSX Venture Exchange under ticker symbol ‘EVGN’. In February 2022, EverGen’s common shares began trading on the OTCQB Venture Market in the U.S. under ticker symbol ‘EVGIF’. The company is headquartered in Vancouver.

Portfolio Projects

Fraser Valley Biogas is one of three projects in EverGen’s portfolio. Located in Abbotsford, British Columbia, the facility has been digesting manure and off-farm organics since 2011 and was the first agricultural digester in Canada to produce RNG. The RNG generated through this project is part of a FortisBC program to supply renewable gas to homes, businesses and other customers. Fraser Valley Biogas also provides Abbotsford farms with renewable fertilizer via the digestate produced. EverGen acquired Fraser Valley Biogas early in 2021 and is currently enhancing and expanding the facility. These optimization projects resulted in record production during the month of September 2021, supporting the growing demand for RNG in British Columbia. Optimization activities contributed an additional 18% of RNG production for September and a 9% higher year-to-date production compared to the previous year. The facility produces approximately 80,000 gigajoules of RNG, enough to heat more than 1,000 homes for a year.

Net Zero Waste Abbotsford, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and RNG expansion project. The British Columbia Utilities Commission recently approved a 20-year offtake agreement between the facility and FortisBC, an electricity and gas utility. Under this agreement, FortisBC will purchase up to 173,000 gigajoules of RNG annually for injection into its natural gas system upon completion of an anaerobic digester project at Net Zero Waste Abbotsford. Once construction is complete, this project is expected to produce enough energy to meet the needs of more than 1,900 homes.

Sea to Sky Soils, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and potential future RNG expansion project which has been operating near Pemberton, British Columbia, on Lil’wat Nation land since 2012. The Lil’wat Nation is a key partner and supporter of the facility, which has employed a majority of its staff from the First Nation since inception. The Sea to Sky Soils facility processed approximately 160 percent of its forecast tonnage in the second half of 2021. In total, Sea to Sky Soils processed approximately 36,000 tons of organic waste in 2021. The facility is working with the Ministry of Environment to expand its operational capacity in 2022. EverGen has partnered with local municipalities – including Metro Vancouver and the municipality of Pemberton – for the delivery of additional organic waste to the facility. The facility is an important part of EverGen’s RNG infrastructure platform and serves as a source of valuable feedstock to support the company’s existing and future operations.

Market Outlook

A report from Global Market Insights states that the biogas market is projected to see significant growth over the next few years, driven by a shifting preference to utilize biogas to reduce emission levels from traditional fuels. Escalating RNG usage by gas utilities as a sustainable and low carbon alternative to supply heat and electricity in industries and buildings will further stimulate growth. RNG is increasingly deployed across the transport sector, especially for heavy vehicles and vessels, to abate GHG emissions.

Many North American gas utilities have set RNG targets of 5% to 15% of production by volume in 2030, compared to less than 1% by volume in 2020. FortisBC has a goal of including 15% RNG in its gas supply by 2030. EverGen believes this presents a potential C$16 billion+ opportunity for RNG producers.

Management Team

Chase Edgelow is co-founder and CEO at EverGen. He has over 15 years of specialized private investment, finance, and technical expertise in the energy and infrastructure sectors. His background is as a Facilities Engineer with Petro-Canada, independently managing energy infrastructure capital projects located in western Canada. He holds a Professional Engineer designation from the province of Alberta.

Mischa Zajtmann is co-founder and President at Evergen. He has 15 years of experience providing consulting and management for Canadian and American companies in the natural resources and energy space. He is a corporate securities lawyer who began his career at Blake, Cassels & Graydon LLP. His J.D. is from the University of Saskatchewan Law School. He’s a member of the British Columbia Bar.

Sean Mezei is COO at EverGen. He has 20 years of experience in the RNG industry, having served previously as the president of Greenlane Biogas and as a senior manager at QuestAir, and founder and president of Dekany Consulting. He was a co-chairman of the American Biogas Council’s RNG working group for six years. He has been a Registered Professional Engineer in the province of British Columbia since 1994.

Natasha Monk is CFO at EverGen. She is a CPA with 12 years accounting, financial reporting, and tax experience in public practice and industry. She is currently a partner at Affirm LLP, where she advises and consults to a wide variety of companies in multiple industries across public and private sectors. Prior to joining EverGen, she worked at KPMG. She graduated from the University of Calgary.

EverGen Infrastructure Corp. (OTCQX: EVGIF), closed Wednesday's trading session at $1.47, up 0%, on volume with 00 trades. The average volume for the last 3 months is 372,474 and the stock's 52-week low/high is $1.365 /$4.00 .

Recent News

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV)

The QualityStocks Daily Newsletter would like to spotlight BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV).

Asthma is a common condition that causes an individual’s airways to swell and narrow, resulting in breathing difficulties, coughing and breathlessness.During childhood, the disease is more prevalent and severe in boys.Following puberty, however, asthma becomes more common and severein women.

Women have a heightened risk of developing this condition becausefemale sex hormones can worsen symptoms of asthma, much like dust, pollen and air pollution does. The hormones may even trigger an asthma attack. It is commonknowledge that women who have asthma are at risk of possibly fatalasthma attacks every month and experience worse symptoms during their periods.

Women between the ages of 20 and 50 who have asthma are also threetimes more likely to be admitted to hospital because of attacks, incomparison to male counterparts of the same age. Prior research hasshown that women are also more likely die as a result of an asthma attack. This is backed by data showing that in thelast five years, more than 5,100 women have died from an asthmaattack, with less than 2,300 men dying of the disease during thesame period.

With entities such as BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) undertaking novel drug-development programs targeting differentindications, including asthma, women could soon have access to moreefficacious remedies for this autoimmune condition that affectstheir quality of life.

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses.

In collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences (MPG) and the University Medical Center Göttingen (UMG), both in Germany, BiondVax is developing a pipeline of innovative nanosized antibody (NanoAb) therapies addressing diseases underserved by current treatments and with large and growing markets, such as COVID-19, asthma and psoriasis.

NanoAbs, also known as VHH-antibodies or Nanobodies, are alpaca-derived nanosized antibodies that exhibit multiple significant competitive advantages over existing antibody therapies, including stability at high temperatures, superior binding affinity, more effective and convenient routes of administration and efficient production. BiondVax is uniquely positioned to advance nanosized antibody innovation from R&D through commercialization.

The company’s highly experienced and successful pharmaceutical industry leadership team includes former senior executives from Novartis, GSK and Bristol-Myers Squibb.

Since its founding, BiondVax has executed eight clinical trials, including a seven-country, 12,400-participant Phase 3 trial of a prior influenza vaccine candidate, and it built, owns and operates a 20,000 sq. ft. state-of-the-art GMP biologics manufacturing facility housing its laboratories, production facilities and offices.

Lead Candidate: Inhaled COVID-19 NanoAb

In December 2021, BiondVax signed definitive agreements with the Max Planck Society – parent organization of the Max Planck Institute for Multidisciplinary Sciences– and the UMG to enter a strategic collaboration for the development and commercialization of innovative COVID-19 NanoAbs.

The company is planning a rapid development path that leverages its expertise and capabilities in biological drug development and manufacturing. BiondVax anticipates preclinical proof-of-concept results for an inhaled COVID-19 NanoAb by the end of 2022, with initial Phase 1/2a human clinical trial results expected in 2023.

The intended inhaled mechanism of delivery of BiondVax’s COVID-19 NanoAb formulation may serve as a significant differentiator when compared to approved monoclonal antibodies, which are injected. Inhaled delivery has shown to be cheaper, more convenient and likely safer for patients and providers.

NanoAb Pipeline: Psoriasis, Asthma and More

The COVID-19 NanoAb development agreement is part of a broader five-year research collaboration agreement signed in March 2022 covering discovery, development and commercialization of NanoAbs for several other disease indications with large market medical needs, including asthma, psoriasis, macular degeneration and psoriatic arthritis.

BiondVax has an exclusive worldwide license for development and commercialization of COVID-19 NanoAbs and exclusive options for similar worldwide licenses for NanoAbs for the above mentioned additional large market disorders currently underserved by approved therapeutic antibodies.

Academic research teams from MPG and UMG have verified strong affinity by the new NanoAbs to their biological target molecules and high thermostability. They have also demonstrated strong neutralization by several NanoAb candidates of their respective target molecules. Neutralization studies of the other NanoAbs are expected to begin later in 2022.

Based on the promising results, BiondVax will focus development efforts beginning with the following NanoAbs:

  • NanoAbs targeting IL-17 as drug candidates for the potential treatment of psoriasis and psoriatic arthritis
  • NanoAbs targeting IL-13 and NanoAbs targeting TSLP as drug candidates for the potential treatment of asthma

These are conditions for which the antibody target is validated by existing treatments and the mechanism of action is well understood. Both represent large medical needs and growing markets. BiondVax anticipates preclinical proof-of-concept for at least one of these NanoAbs in 2023. This is in addition to the aforementioned human clinical Phase 1/2a for the inhaled COVID-19 NanoAb therapy, which is also anticipated in 2023.

Market Opportunity

COVID-19 treatment, target of the company’s lead NanoAb therapy candidate, had an estimated market size of $22 billion in 2021.

Future BiondVax drug candidates will target conditions with large markets growing at attractive CAGRs.

The global asthma treatment market was valued at $18.08 billion in 2019 and is projected to reach $26.01 billion by 2027, exhibiting a CAGR of 4.5% during the forecast period, according to Fortune Business Insights. The research firm predicts that the global psoriasis treatment market will grow from $26.37 billion in 2022 to $47.24 billion by 2029, exhibiting a CAGR of 8.7% over the forecast period.

Management Team

Amir Reichman is BiondVax’s CEO. He previously was Head of Global Vaccines Engineering Core Technologies at GSK Vaccines in Belgium. Prior to that, he held leadership roles at Novartis Vaccines’ Global Vaccines Supply Chain Management organization. He was the first employee of NeuroDerm Ltd., a company focused on transdermal drug delivery, and served as Chief Engineer and Senior Scientist until his departure in 2009. He earned a M.Sc. in Biotechnology Engineering from Ben-Gurion University and an MBA in Finance and Health Care Management from the University of Pennsylvania’s Wharton School.

Tamar Ben-Yedidia, Ph.D., is Chief Science Officer at BiondVax. She has more than 30 years of experience in immunology, with specific expertise in the development of vaccines. She began her career with Biotechnology General Ltd., working on development of a recombinant Hepatitis-B vaccine. She later joined the Weizmann Institute of Science, working on the design of a peptide-based vaccine against several pathogens. She is widely published, with numerous refereed articles and invited reviews in various scientific journals. She received her Ph.D. from the Weizmann Institute.

Elad Mark is COO at BiondVax. He has over 15 years of biotechnology industry experience encompassing diverse project stages including feasibility studies, conceptual and detailed design, commissioning, qualification and process validation. Prior to joining BiondVax, he led Novartis’s $800 million investment in a biologics facility in Singapore. With Biopharmax and Antero, both global pharmaceutical engineering companies, he successfully led projects in Israel, China and Singapore. He holds a BSc. in Engineering from the Afeka Tel Aviv Academic College of Engineering and an MBA from the Open University of Israel.

Uri Ben-Or is CFO at BiondVax. He has served as CFO with public life science companies traded on the TASE, OTC and Nasdaq. Ben-Or provides his services to BiondVax through CFO Direct, a company he founded and for which he serves as CEO. He served as the VP of Finance of Glycominds, a leading biotechnology company, and as CFO of a spin-off from Telrad Networks. He also served as a Corporate Controller at Menorah Capital Markets and as an Auditor at PWC. He holds a B.A. in Business from the College of Administration, an MBA from Bar-Ilan University, and is a CPA.

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), closed Wednesday's trading session at $3.24, up -0.613497%, on 23,773 volume with 00 trades. The average volume for the last 3 months is 145.407M and the stock's 52-week low/high is $3.0914 /$34.90 .

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.